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Abbreviations
2D – Two-dimensional echocardiography
3D – three-dimensional echocardiography
A2C – Apical two chamber
A3C – Apical three chamber
A4C – Apical four chamber
A5C – Apical five chamber view
AF – Atrial Fibrillation
ALC – Antero-Lateral Commissure
A-L – Antero-Lateral
A-P – Anterior-Posterior
AR – Aortic Regurgitation
BMV – Balloon Mitral Valvuloplasty
BSA – Body Surface Area
BSE – British Society of Echocardiography
CABG – Coronary Artery Bypass Grafting
CFD – Colour Flow Doppler
CSA – Cross-sectional area
CW – Continuous Wave Doppler
DCM – Dilated Cardiomyopathy
DT – Deceleration Time
ECG - Electrocardiogram
EROA – Effective Regurgitant Orifice Area
ESV – End-Systolic Volume
GLS – Global Longitudinal Strain
HFpEF – Heart Failure with preserved Ejection Fraction
HR – Heart Rate
IAS – Inter Atrial Septum
IC – Inter-Commissural distance
LAA – Left Atrial Appendage
LA – Left Atrium
LAP – Left Atrial Pressure
LVEDV – Left Ventricular End-Diastolic Volume
LVEDD – Left Ventricular End-Diastolic Diameter
LVEF – Left Ventricular Ejection Fraction
LVESD – Left Ventricular End-Systolic Diameter
LV - Left Ventricle
LVOT - Left Ventricular Outflow Tract
MAD – Mitral Annular Disjunction
mLAP – Mean Left Atrial Pressure
mL - Millilitre
MR - Mitral Regurgitation
MS – Mitral Stenosis
MVA – Mitral Valve Area
MVG – MitralValve Gradient
MVP – Mitral Valve Prolapse 
MV – Mitral Valve
P½t – Pressure Half-Time
PA – Pulmonary Artery
PH – Pulmonary Hypertension
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PISA – Proximal Isovelocity Surface Area
PLAX – Parasternal Long Axis
PMC - Percutaneous Mitral Commissurotomy
PSAX – Parasternal Short Axis
PulV D – Pulmonary Vein Diastolic velocity
PulV S – Pulmonary Vein Systolic velocity
PW – Pulsed-Wave Doppler
PM – Papillary Muscle
P-M – Postero-Medial
PV – Pulmonary Veins
RF – Regurgitant Fraction
RLPV – Right Lower Pulmonary Vein
ROI – Region of Interest
RV – Right Ventricle
SBP – Systolic Blood Pressure
SCD – Sudden Cardiac Death
SLE - Systemic Lupus Erythematosus
SPAP – Systolic Pulmonary Artery Pressure
SV – Stroke Volume
TAPSE – Tricuspid Annular Plane Systolic Excursion
TLAEF – Total Left Atrial Emptying Fraction
TOE – Transoesophageal Echocardiography
TTE – Transthoracic Echocardiography
TV – Tricuspid Valve
VC – Vena Contracta
VR – Volume rate
VTI – Velocity Time Integral 
WHO – World Health Organisation
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Abstract
Mitral valve disease is common. Mitral regurgitation is the second most frequent indication 
for valve surgery in Europe and despite the decline of rheumatic fever in western societies, 
mitral stenosis of any aetiology is a regular finding in all echo departments. Mitral valve 
disease is therefore one of the most common pathologies encountered by echocardiographers, 
as both a primary indication for echocardiography and a secondary finding when 
investigating other cardiovascular disease processes. 
Transthoracic and transoesophageal echocardiography (TOE) play a crucial role in the 
assessment of mitral valve disease and are essential to identifying the aetiology, mechanism 
and severity of disease and for helping determine the appropriate timing and method of 
intervention.
This guideline, from the British Society of Echocardiography (BSE), describes the 
assessment of mitral regurgitation and mitral stenosis and replaces previous BSE guidelines 
describing the echocardiographic assessment of mitral anatomy prior to mitral valve repair 
surgery and percutaneous mitral valvuloplasty. It provides a comprehensive description of the 
imaging techniques (and their limitations) employed in the assessment of mitral valve 
disease. It describes a step-wise approach to identifying: aetiology and mechanism, disease 
severity, reparability and secondary effects on chamber geometry, function and pressures. 
Advanced echocardiographic techniques are described for both transthoracic and 
transoesophageal modalities, including TOE and exercise testing.
Word Count - 19332
Key words - Mitral regurgitation, mitral stenosis, transthoracic echocardiography, 
tranoesophageal echocardiography
Running Head – BSE Mitral Valve Guideline
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Imaging planes -       2D TTE imaging planes 
-    3D TTE imaging planes
Doppler Assessment of Flow






Aetiology and mechanism (Carpentier’s classification)
            Grading mitral regurgitation severity
Key anatomical findings
Qualitative parameters
   -Colour Flow Doppler (jet area and direction as indicator of mechanism)
                           -Continuous Wave Doppler – (waveform density and timing, early vs late)
Quantitative parameters
  -Proximal Isovelocity Surface Area (regurgitant volume and effective 
regurgitant orifice area)
   -Vena Contracta (2D and 3D)
   -Continuity equation (regurgitant volume and regurgitant fraction)
                       Supportive parameters of haemodynamically severe MR
    - Pulmonary vein flow, E velocity, E/A ratio
Atrial fibrillation
Considerations for intervention
              Surgical intervention
              Percutaneous intervention
Haemodynamic consequences 
Effect on left heart chambers- Left atrium volume
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                           Global longitudinal left ventricular strain
                           Left atrial function analysis
                                        Proportionality of MR
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INTRODUCTION: BASIC CONCEPTS
Mitral valve anatomy
Normal mitral valve anatomy
The normal mitral valve (MV) sits at the junction between the left atrium (LA) and left 
ventricle (LV). It is a complex anatomical structure composed of several distinct but 
contiguous structures: a fibro-muscular annulus, two leaflets, tendinous chords and papillary 
muscles1. In order to identify abnormal mitral anatomy and accurately diagnose disease 
severity, it is essential that echocardiographers possess a comprehensive understanding of 
normal mitral valve structure and function1,2.
Leaflets
Standard imaging practice describes the two MV leaflets according to their general 
anatomical positions, anterior and posterior3,4. Geometry of the anterior and posterior leaflets 
is quite different. The posterior leaflet is short in length, usually 11-14 mm, inserting along 
two-thirds of the annular circumference5,6. In contrast, the anterior leaflet is longer, normally 
18-24 mm, but involves only one-third of the total annular circumference6; the anterior and 
posterior leaflets meet in the margins at the anterolateral and posteromedial commissures2. 
Along the free edge of the posterior leaflet are a series of indentations that divide the 
posterior leaflet into three scallops of roughly equal size: P1, P2 and P33. Although similar 
indentations are not present on the anterior leaflet, the corresponding regions opposing the 
posterior scallops are labelled A1, A2 and A33. Where the two leaflets meet is referred to as 
the zone of coaptation. The coaptation zone (leaflet apposition) is at least 5 mm in height in a 
competent mitral valve1. 
Chordae Tendineae
The mitral leaflets are connected to the LV by support chords, extending from the papillary 
muscle, known as chordae tendineae3. The chordae tendineae provide varying degrees of 
tensile support throughout systole. The classification of either primary, secondary or tertiary 
chords describes the insertion point, which in-turn identifies the degree of load-bearing3. 
Primary chords insert into the free-edge of the leaflet, preventing leaflet prolapse and 
ensuring the leaflet tips meet in coaptation; primary chords do not bear significant loads6. 
Secondary chords insert into the ventricular surface of the leaflet at the junction between the 
rough zone and the clear zone and are able to bear the significant systolic load by spreading it 
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evenly throughout the leaflets3,6. Tertiary chords insert into both the base of the posterior 
leaflet and basal LV wall, connecting the posterior leaflet and annulus to the papillary 
muscle, thereby maintaining ventricular-valve continuity3.6
Papillary muscle
When mitral morphology is normal, chordae tendineae extend from typically two groups of 
papillary muscle (PM), antero-lateral and postero-medial3. The antero-lateral (A-L) PM is 
usually the largest, comprised of two heads arising from a single projection at the mid to 
apical border between the lateral and infero-lateral wall3. The postero-medial (P-M) PM 
extends from multiple myocardial projections from the mid to apical inferior wall, 
comprising three heads (anterior, intermediate and posterior)3,6. Each PM supplies chords to 
both leaflets: the antero-lateral PM to P1, A1 and medial portions of P2 and A2, while the 
postero-medial PM supplies P3, A3 and lateral portion of P2 and A2; the commissures are 
supported by chordal attachments from the PM directly beneath3. Contraction of the PM and 
surrounding myocardium increases the chordal tensile support, maintaining leaflet 
coaptation6. The postero-medial papillary muscle is typically perfused by a single coronary 
artery, the posterior descending artery (PDA). The PDA extends from the right coronary 
artery in around 70-80% of patients, the left circumflex artery in 5-10% and from both left 
and right coronary systems in 10-20% of patients.  The AL PM is typically perfused by the 
Left Anterior Descending (LAD) coronary artery and the diagonal or marginal branch of the 
circumflex.
Mitral Annulus
The mitral leaflets insert at the transition between atrial and ventricular myocardium, the 
atrioventricular junction4. As a result, the posterior mitral annulus is muscular. The anterior 
annulus consists of fibrous tissue made up of the left and right trigones and is continuous 
with the fibrous skeleton of the heart. The annulus is a saddle-shaped structure with high 
points anterior and posteriorly. The muscular posterior annulus region is more prone to 
dilation than the rigid fibrous anterior annular region3, owing to the anterior region being in 
fibrous continuity with the skeleton of the heart.
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Fig 1. 
Transthoracic echocardiography (TTE) Imaging planes 
Due of the tomographic nature of TTE, it is necessary to view the mitral valve in a number of 
2D TTE scanning planes in order to perform a complete anatomical and functional 
assessment. Imaging from both the parasternal and apical windows provides a comprehensive 
assessment of all mitral components and allows for identification of distinct valvular 
structures and an assessment of their function1. 
2D TTE assessment
Parasternal long-axis (PLAX). During routine TTE, the mitral valve is first seen in the 
PLAX window. In this view the imaging plane is through the centre of the mitral valve, 
demonstrating A2 of the longer anterior leaflet and P2 of the shorter posterior leaflet (Table 
1, image 1); the postero-medial papillary muscle may be seen extending from the infero-
lateral (posterior) LV wall 1,7. With an inferior tilt of the ultrasound beam (towards the RV 
inflow and tricuspid valve view) it is possible to image scallops A3/P3 (Table 1, image 7), 
further tilting will bring into view the postero-medial commissure. A superior tilt of the beam 
(moving towards the RV outflow and pulmonary view) will demonstrate scallops A1/P1 and 
eventually the antero-lateral commissure (Table 1, image 6). The anterior and posterior 
regions of the mitral annulus are visualised in this view.
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Parasternal short-axis (PSAX). Orthogonal to the long-axis plane are the short-axis views 
of the left heart. At the level of the mitral valve leaflets, the ventricular surface of all scallops 
and both commissures can be visualised in their entirety (Table 1, image 8). From the level of 
the valve, tilting inferiorly (towards the apex) will bring into view both papillary muscles 
(Table 1, image 10). Consistent with the commissures they support, the postero-medial PM is 
seen on the left and the antero-lateral on the right7 (Fig 1).  
Apical four chamber (A4C). An oblique plane of the anterior leaflet is seen in the A4C with 
scallops A3, A2, A1 seen from left to right, P1 of the posterior leaflet is seen (Table 1, 
images 12 and 13). In this plane the antero-medial and postero-lateral regions of the mitral 
annulus are viewed. The superior position of the MV annulus relative to the tricuspid annulus 
(further from the apex) is appreciated best in this view7. The normal inter-annular off-set 
distance is 5-11 mm. If MV and TV annular planes are seen at the same level or there is an 
inter-annular distance exceeding 11 mm (8 mm/m2)8 this may be associated with congenital 
abnormalities (Ebsteins’s anomaly where the TV is displaced towards apex, or Atrio-
Ventricular Septal Defects with annular planes at the same level). 
Apical two chamber (A2C). Rotating the probe anti-clockwise until the right heart is no 
longer imaged demonstrates the A2C view. When scanning in this window, also referred to 
as the bi-commissural view, the plane of imaging is along the line of leaflet coaptation, such 
that A2 is seen in the centre of the valve with P3 and P1 seen on the left and right 
respectively (Table 1, images 14 and 15). The postero-medial and antero-lateral aspects of the 
MV annulus are seen1,7.
Apical three chamber (A3C). Further rotation brings the central portion of the MV into 
view. Similar to the PLAX view, A2 and P2 are visualised (Table 1, images 16 and 17).
3D TTE assessment
3D volume assessment 
Volumetric datasets acquired during 3D imaging provide visualisation of the valve from any 
angle or in any plane. Manipulation of the datasets allows for the assessment of the valve 
from the perspective of the left atrium, demonstrating the specialist view of the MV known as 
the ‘surgeons view’7. In this view, by displaying the aortic valve at the top centre of the 
image (12 o’clock) and the left atrial appendage to the left (9 o’clock), scallops one to three 
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are seen from left to right (Table 1, image 9). The TTE MV datasets can be acquired in either 
the parasternal or apical views. The parasternal window often provides better 3D image 
quality of the MV. This is in part due to the proximity of the valve to the ultrasound probe, 
and the superior image resolution of the axial plane over that of the lateral when the valve is 
closed in systole. However, in this orientation the MV leaflets are parallel to the scan lines 
and drop-out may occur, particularly when leaflets are thin.  When imaging in the apical 
window, more scan lines are utilised to image the MV during the cardiac cycle and 
compensate for the lower azimuthal and elevation resolution. As a result, it may be easier to 
obtain good quality 3D datasets of the MV from the apical approach. 3D zoom provides 
superior imaging of the valve in comparison to full-volume and Live 3D modalities. Image 
optimisation is achieved by adjusting the area of interest to include the entire annulus and 
leaflet tips in both orthogonal viewing planes, ensuring to include the entirety of the non-
planar annulus. Although stitching of the dataset over two, four or six beats increases 
imaging volume (frame) rates (VR) and improves temporal resolution, variable R-R intervals 
secondary to atrial fibrillation (AF) or respiratory motion can lead to stitching artefact and 
dyssynchronous motion of the volumes within the dataset1,7. Breath-holding may avoid such 
artefacts.
Advances in ultrasound technology have enabled the acquisition of high VR 3D datasets with 
the addition of Colour Flow Doppler (CFD), a modality until more recently limited by its   
reduced temporal resolution of the 3D volumes. By integrating CFD into the 3D dataset, it is 
possible to identify the 3D PISA and Vena Contracta (VC) and permits simultaneous VC 
measurement in orthogonal planes1.
3D dataset for orthogonal planes 
The matrix arrangement of piezoelectric elements within the head of the 3D probe enables 
the generation of a conical volume dataset. When creating 3D imaging, all elements within 
the matrix are utilised to create the volumetric dataset. However, when two perpendicular 
element lines are activated instantaneously it is possible to display orthogonal imaging planes 
simultaneously, providing greater insight into the extent of valvular pathology or improved 
alignment with valvular anatomy (Table 1, image 5). Simultaneous multi-plane imaging 
(such as Xplane or Multi-D) provides a second scan plane which initially displays an 
orthogonal view to the primary (live) imaging plane. The position of the second imaging 
plane can be adjusted (using rotation or tilt function) to demonstrate a simultaneous view of 
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any anatomy within the primary image9. Although the imaging planes are usually orthogonal, 
the second image can be at any degree of rotation from the primary image. This form of 
imaging allows visualisation of the MV through from the lateral to the medial aspect of the 
coaptation line (segmental analysis). The MV anatomy and therefore mechanism of valve 
failure can be assessed in detail. Any focal lesions such as prolapse can therefore be located 
accurately.
Table 1. MV anatomy and TTE imaging view
Doppler Assessment of Flow
Proximal Isovelocity Surface Area – PISA
When liquid flows from a large chamber through a smaller orifice at a fixed rate, flow 
velocity increases to a point at which it is greatest as it converges on the narrowest region of 
the flow10. When the orifice is planar, rounded and narrow, this flow convergence occurs in a 
hemi-spherical geometry (Fig 2) with a velocity that is equal throughout the hemi-sphere 
surface. These flow convergence hemi-spheres are better identified on echo by reducing the 
CFD velocity at which blood flow aliases (Nyquist limit) to between 20 and 40 cm/s in the 
direction of the flow. Doing so identifies the hemi-sphere moving at our selected velocity in 
the direction of the orifice and allows measurement of the hemi-sphere height (Fig 2). Since 
flow velocity increases as blood approaches the regurgitant orifice, the relationship between 
PISA radius and Nyquist limit is inverse (PISA height increases as the Nyquist limit is 
reduced)1
Since the rate of flow throughout the convergent shells and orifice is equal (volume does not 
alter with changing geometry, only velocity changes), the flow rate through the orifice (ml/s) 
can be calculated by multiplying the surface area of the hemi-sphere (2r2) by the velocity 
(20 – 40 cm/s) of the flow at that point11. The orifice area can then be calculated by dividing 
the flow rate by the velocity of the flow through the valve (equation 1). 
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Fig 2 
Equation 1 – PISA calculations for MR
Hemisphere surface area = 2  ( radius2)× ×  
MR flow-rate = Hemisphere surface area  CF Doppler Nyquist velocity×
EROA = MR flow-rate  MR peak velocity (cm/s)
Regurgitant volume = EROA  MR VTI×
Continuity equation
Based on the theory of conservation of mass, the continuity method of estimating flow 
volumes can provide estimates of both mitral valve area (MVA) and regurgitant volume11. 
The theory of conservation of mass assumes that in a closed hydraulic system the volume of 
flow through two regions is equal and that any change in velocity, and therefore VTI, 
between the two sites is determined by differences in anatomy between them. 
 For MVA
When applying this calculation to estimate MVA, the left heart stroke volume (SV) is 
calculated at the site of the left ventricular outflow tract (LVOT) by multiplying the 
LVOT cross-sectional area (CSA) by the LVOT VTI (equation 2). 
Equation 2 – LVOT SV
LVOT CSA  LVOT VTI×
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Assuming SV is same through both the LVOT and MV orifice, the equation can be 
rearranged and the MVA can be calculated as:
Equation 3 – MVA 
CSA (MVA) = LVOT SV/MV VTI12.
 For MR volume
When both mitral and aortic valve function is normal, the SV leaving the LV through 
the LVOT is the same volume of blood that enters the LV through the MV. When MR 
is present however, the trans-mitral SV in diastole is greater than the SV through the 
LVOT in systole (due to the normal filling volume combined with returning 
regurgitant volume from the previous systolic cycle). On this assumption, the 
presence of MR will result in a greater SV through the MV in diastole in comparison 
to through the LVOT in systole, the difference being the volume of MR12. 
Equation 4 – MR volume
MR volume = MV SV (MVA MV VTI) - LVOT SV×  
Pressure half-time
As described above, when blood flows across a stenotic valve in a normal flow state (normal 
SV and normal ejection time), the velocity of flow is determined by the pressure difference 
across the narrowed valve, which in turn is determined by the degree of stenosis1. 
Furthermore, in addition to pressure gradient and maximum velocity of flow, the degree of 
stenosis will also affect the time it takes for pressures either side of the stenosis to equalise 
and for the blood flow velocity to fall by half the starting value (P½t). When the valve opens 
fully, the volume and rate of flow across the valve remains normal. In this normal state, the 
rapid flow of volume across the valve results in rapid equalisation of pressure either side of 
the valve (the transfer of volume causes a fall in pressure within the chamber it exits (LA) 
and an increase in pressure within the chamber it enters (LV), to the point that pressures 
eventually equalise). Since pressure differences determine the velocity of blood flow, a rapid 
fall in pressure difference will result in a rapid fall in blood flow velocity. This is reflected by 
a very short time for the trans-mitral blood flow velocity to fall by half the starting value and 
therefore a steep E wave deceleration slope. Conversely, when stenosis is severe and valve 
opening is significantly restricted, the volume of flow across the valve is reduced, leading to 
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reduced filling of the LV and consequently low LV diastolic filling pressures. However, the 
reduction of flow across the MV prevents adequate emptying of the LA with subsequent 
volume and therefore pressure overload and a significant diastolic pressure difference 
between the LA and LV is maintained. Because high pressure difference is maintained 
throughout diastole, the time taken for the pressure difference to fall by half is extended1,13. 
This is reflected by continually high trans-mitral flow velocity throughout diastole and 
therefore a shallow E wave deceleration slope. Therefore, the rate of pressure decay (and thus 
the rate at which blood flow velocity falls) is considered reflective of the degree of valve 
opening and inversely proportional to the valve area13. It is on this basis that estimates of P½t 
can be utilised to estimate MVA. 
When assessing mitral stenosis, the rate of pressure decay can be measured and utilised to 
calculate valve area (equation 5) where 220 is a constant that is proportional to the assumed 
net compliance of the LA and LV. MVA can then be calculated13 by:




As mentioned previously, the flow of blood through the circulatory system relies on the 
existence of pressure differentials between two regions, the direction and velocity of flow 
being determined the magnitude of pressure difference between them1. When narrowing’s 
occur along the path of flow, pressure builds prior to the obstruction creating a pressure 
gradient across it that increases as the narrowing worsens. As flow velocity is determined by 
pressure differences (velocity increases as the pressure difference increases), progressive 
narrowing of anatomy will lead to a gradual increase in the pressure gradient and therefore 
flow velocity through the narrowed region. Because echocardiography measures the velocity 
of blood flow through the heart, not the pressure difference driving the flow, the simplified 
Bernoulli equation is applied to calculate pressure difference from the measured velocity14 
(equation 6):
Equation 6 – simplified Bernoulli equation
4 × (Velocity2)
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This notion can be applied to the assessment of the stenotic mitral valve where mild stenosis 
is associated with a small pressure gradient and low velocity across the valve while severe 
stenosis results in a high trans-valvular pressure gradient and high blood flow velocity. 
Vena Contracta
The Vena Contracta is the narrowest region of the regurgitant jet as it flows into the LA. It 
occurs immediately downstream of the regurgitant orifice and is slightly smaller in CSA than 
the anatomical regurgitant orifice15,16. Although the VC measured by CFD is influenced by 
loading conditions and flow-rate due to incorporation of blood mass already within the LA, 
the VC remains an effective measure of regurgitant orifice area and therefore MR severity, 
with particular strength in eccentric jets. 
MITRAL REGURGITATION
Aetiology and Mechanism
Mitral regurgitation is the most common valvular abnormality in developed countries and is 
the second most frequent indication for valve surgery in Europe19. MR can be broadly 
categorised into primary, with intrinsic abnormalities of the leaflet and/or subvalvular 
apparatus or secondary (functional) when mitral valve anatomy is normal but abnormalities 
of the LV and/or LA disrupt normal valvular function1,12. 
It is important to define the underlying aetiology of MR since the disease type informs 
management. For example, mitral valve prolapse typically results in valve repair19, whereas 
secondary ischaemic MR will first require heart failure optimisation with optimal medical 
therapy, may include cardiac resynchronisation therapy and possibly transcatheter 
intervention20. The commonest causes of MR include degenerative disease (also referred to as 
mitral valve prolapse (MVP)) accounting for around 60%, rheumatic valve disease seen in 
15% and secondary MR responsible for approximately 20% of all cases1. A particular 
aetiology may result in a combination of mechanistic failures (Fig 3). 
An understanding of the mechanism of valve failure is critical in determining patient 
selection for suitability of valve intervention, including repair. However, it should be noted 
an appreciation of the anatomical abnormalities additionally ensures the extent and severity 
of the MV lesion is not underestimated. The mechanism is defined according to leaflet 
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motion using Carpentier's classification21 (Table 2) and can be: normal, MR results from 
isolated annular dilatation (either from LA or LV dilatation) or leaflet perforation (type 1); 
excessive, MR results from leaflet prolapse (type 2); restricted, MR can be due to leaflet 
restriction and retraction, (type 3a) or LV remodelling with underlying wall motion 
abnormalities, (type 3b). Additionally, the MR jet direction lends important clues to the 
underlying mechanism of valve failure and their potential aetiologies (Table 3). A flail 
segment from chordal rupture or identification of complete loss of coaptation with a 
coaptation gap are two specific mechanisms indicative of severe valve regurgitation, see echo 
descriptors below for details of definitions.
Table 2 - Carpentier’s classification
Figure 3
Table 3 - Mechanisms and jet direction
Grading mitral regurgitation severity
The degree of mitral regurgitation is heavily influenced by variations in heart rate and blood 
pressure22. It is therefore essential that these parameters are documented in each report and 
considered when comparing serial echo findings. In addition, height, weight and body surface 
area should always be recorded. Values indexed to patient size provide background context to 
the absolute dimensions and parameters of LA and LV volume and provide important 
prognostic information (see later sections for details).
Key anatomical findings
Although MR severity cannot be quantified by the appearance of anatomy alone, certain 
anatomical characteristics are associated with severe MR. A flail leaflet segment (eversion of 
the leaflet tip into the LA) identifies a major coaptation defect and is associated with severe 
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regurgitation1. Similarly, frank loss of leaflet coaptation (also referred to as coaptation gap) 
denotes a large regurgitant orifice and the presence of severe MR (Table 8, image 1-3).
Qualitative parameters
Colour Flow Doppler (Jet area and direction as indicator of mechanism) 
Colour Flow Doppler (CFD) allows both qualitative and quantitative assessment of the MR 
severity and helps identify the regurgitant mechanism. When investigating MR by CFD, the 
regurgitant jet should be assessed in all available views, both on-axis and off-axis, to gain a 
full appreciation of jet origin, size and PISA (Table 8, images 5-10). In doing so, it is possible 
to identify the three regions of the regurgitant jet (Fig 4): flow convergence on the ventricular 
surface of the leaflets (PISA), the narrower portion/neck of the jet as it transverses the 
regurgitant orifice (Vena Contracta) and the jet expansion within the LA.
Fig 4. 
The initial identification of MR and basic evaluation of severity is based on the visual 
interpretation of jet size by colour flow Dopppler23; the principle being that greater MR 
severity results in a larger jet within the LA (Table 8, images 5-10). However, this method 
requires a qualitative interpretation of MR appearance and is therefore subject to intra and 
inter-observer variation. A semi-quantitative analysis of MR CFD can be performed by 
tracing the CFD signal within the LA (jet area) and can be used as a stand-alone indicator of 
MR severity. When combined with LA size measurement, the percentage of LA area the MR 
jet fills can also be calculated23. A value >50% being suggestive of severe MR23 (Table 8, 
image 10). It is important to note the Nyquist limit should be 50-60 cm/s range and colour 
gain optimized. 
However, these methods are limited by a number of technical and haemodynamic factors that 
influence the CFD jet appearance and size24. For a given MR severity, unoptimised scan 
settings (Nyquist limit outside of the 50-60 cm/s range or unadjusted colour gain) will lead to 
over or underestimation of MR severity. Low driving force (low SBP) and therefore reduced 
MR volume, increases in LA pressure (LAP) through mitral stenosis (MS) or LV diastolic 
dysfunction, increases in LA size, and jets that adhere to the LA wall due to Coanda effect 
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will all result in significant underestimation of MR severity24. Therefore, although CFD 
should be used to identify the presence of MR, it should not be used in isolation to quantify 
severity1,24. However, by identifying the origin and direction of MR, CFD is crucial in 
distinguishing the mechanism of regurgitation (Table 3).
3D TTE provides instantaneous assessment of all segments of each leaflet, the commissures 
and annulus. The MV can be viewed in real-time from the surgeon’s perspective (‘surgeons 
view’) within the LA (Table 1, image 9).  The location of lesion(s), site of regurgitation (3D 
colour) and extent of disease can be rapidly appreciated. 3D colour flow Doppler mapping of 
mitral regurgitation allows the regurgitant jet to be assessed in all planes, particularly useful 
in the analysis of eccentric mitral regurgitation or visualization of multiple jets25. In addition, 
because 3D echocardiography provides live assessment of the whole MV anatomy and 
function from the atrial perspective, a great advantage of 3DE, compared to either the 
anatomist or the surgeon’s view, is the ability to assess the real-time functional anatomy 
(anatomy of the MV in the beating heart) of the valve, this is particularly useful in the 
assessment of primary MR 
Continuous Wave Doppler (waveform density and late systolic MR)
The density and velocity of the CW Doppler signal can also be used as a qualitative guide to 
MR severity. Because CW signal density is proportional to the number of blood cells within 
the region of sampling, dense signals are suggestive of more severe MR while faint signals 
are suggestive of mild regurgitation26. Additionally, because of rapid pressure equalisation, a 
triangular waveform with peaking in early systole is suggestive of very severe or torrential, 
often acute MR1,12 (Table 8, images 11-12). 
Furthermore, for a given EROA, the associated MR volume will vary according to the 
duration of regurgitant flow, such that jets of brief duration are of less volume than pan-
systolic MR. Since leaflet prolapse is a dynamic process that often results in late or end-
systolic MR, the volume of associated regurgitation, and therefore MR severity, is less than 
the CFD appearance and EROA suggest. It is therefore recommended that the severity of 
end-systolic MR is based on PISA estimated regurgitant volume, rather than EROA1. 
Under normal circumstances and with normal systolic blood pressure MR velocity is high, 
usually reaching 5-6 m/s. Low MR velocity is therefore suggestive of reduced SBP 
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(potentially a sign of decompensation in severe MR) or high left atrial pressure and reduced 
pressure difference between the LV and LA, often indicative of severe MR27. 
Quantitative Assessment of MR
Vena Contracta
As MR flows from the area of convergence within the LV (PISA), through the valve and into 
the LA, it narrows at a point within the LA immediately superior to the regurgitant orifice, 
this region is described as the Vena Contracta (VC) (Fig 4). The VC is reflective of the 
regurgitant orifice area and can be measured as an indicator of MR severity. When performed 
during TTE, it should be measured in any view where the three components of the regurgitant 
jet are seen (Table 8, image 14). The principle of VC measurement assumes that the 
regurgitant orifice is of circular geometry with similar diameter in orthogonal planes1. 
However, the regurgitant orifice geometry in secondary MR is typically elliptical12, the 
profile being narrower in the A4C view and wider in the A2C view due to the orientation of 
the line of leaflet coaptation (Table 8, images 14-15). Measurement should therefore be 
averaged from near-orthogonal planes, usually the A4C and A2C views, and should be 
averaged over two to three beats. As a direct measure of effective regurgitant orifice 
geometry, assessment of VC is particularly useful for the assessment of eccentric MR jets 
when other methods of grading MR severity are less accurate. An average VC <3mm 
suggests mild MR while a VC >8mm is consistent with severe MR irrespective of 
aetiology15; >7 mm is suggestive of severe MR when VC is measured in a single plane.  
Because of the near-orthogonal measurement planes, accurate depiction and careful 
measurement of the vena contracta (both 2D and 3D) will avoid the risk of MR 
underestimation when the regurgitant orifice is non-circular. Therefore, the routine use of VC 
(averaged between A4C and A2C) is encouraged in secondary MR quantification.15
However, imaging must be optimised to ensure perpendicular alignment with the regurgitant 
orifice to allow accurate measure of the VC. Furthermore, since multiple measurements 
cannot be combined to estimate overall MR severity, the VC estimation is limited when 
multiple jets are present. As described previously, overall severity is overestimated when MR 
occurs in late systole only. If available, use of 3D echo formats such as biplane imaging to 
assess the VC in simultaneous orthogonal views or 3D zoom CFD can aid in identifying the 
regurgitant orifice morphology15. 
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While prognostic data is lacking, 3D vena contract area is increasingly utilised and when 
combined with Doppler parameters may better define the EROA and regurgitant volume, 
avoiding underestimation. The threshold for severe MR has been defined as >40mm2 22. 
Proximal Isovelocity Surface Area (regurgitant volume and effective regurgitant orifice area)
The PISA method is the recommended quantitative approach to identifying MR severity 
whenever feasible24. Although PISA measures are usually made in the A4C view, the PLAX 
may provide better alignment with regurgitant flow in cases of posteriorly directed eccentric 
MR (ischaemic MR, anterior leaflet prolapse) (Table 8, image 17). As previously described, 
the flow convergence hemi-spheres are identified by reducing the Nyquist limit in the 
direction of flow to between 20 and 40 cm/s, PISA radius is then measured in mid-systole 
and the calculation for regurgitant orifice area (EROA) performed (Table 8, image 16). Once 
the EROA has been calculated and the MR CW signal traced to measure VTI, the continuity 
equation is applied to calculate regurgitant volume (Table 3). 
The PISA method assumes a circular regurgitant orifice, with flow convergence volumes of 
hemi-spherical geometry. Although this is more likely with primary regurgitation, the 
elliptical EROA typically associated with secondary MR produces a hemi-ellipsoid PISA 
geometry (see Fig 4). Therefore, the functional MR PISA dimension is greater in the 
horizontal plane versus the vertical, true regurgitant severity is underestimated when 
secondary MR assessment is based on PISA height alone. To account for this 
underestimation, the threshold for identifying severe secondary MR based on the EROA may 
be lower than that of primary MR. 
It is important to note the limitations of PISA calculations in differing aetiologies of MR and 
where the MR jet duration may vary.  Firstly, the PISA radius can be dynamic. Although it is 
usually constant throughout systole in those with rheumatic MR (where the valve orifice is 
relatively fixed), PISA increases progressively through systole in those with leaflet prolapse 
and demonstrates early and late systolic peaking in those with secondary MR28. Secondly, for 
a given EROA, the associated MR volume will vary according to the duration of regurgitant 
flow, such that brief jets are of less volume than pan-systolic MR (Table 8, image 19-20). 
Since leaflet prolapse is a dynamic process and may be associated with late or end-systolic 
MR, the volume of resultant regurgitation, and therefore MR severity, is less than the CFD 
appearance and EROA suggest1,15. It is therefore recommended that the severity of end-
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systolic MR is based on PISA estimated regurgitant volume, rather than EROA. Colour M-
Mode can be used to determine the point at which PISA is at its greatest and help identify the 
correct timing of CW peak velocity for EROA estimation (Table 8, image 18)
Continuity equation (regurgitant volume and regurgitant fraction)
By estimating the SV at the level of the MV and at the LVOT, the continuity equation can be 
applied to perform a simple estimate of MR volume15. By subtracting the SV estimate at the 
level of the LVOT from SV estimate at the level of the MV, the volume of MR is calculated 
as the difference between the two sites
However, the accuracy of this method is limited by the multiple measures involved and by 
the assumption that both LVOT and MV orifice cross-sectional area (CSA) are perfectly 
circular1. As both are usually more elliptical than circular, estimating CSA (r2) based on a 
single two-point diameter measure will, depending on whether the major or minor axis of the 
anatomy has been measured, result in under or overestimation of the true CSA12. When 
image quality permits, Simpsons biplane or more accurately 3D estimates of LV total SV can 
be substituted for trans-mitral Doppler estimates of LV SV, ie (EDV-ESV) - LVOT SV = 
MR volume. However, this method performs a direct comparison of SV and assumes the 
difference between the two represents the MR volume. Accuracy is significantly reduced in 
the scenarios when a SV mismatch exists for reasons other than MR, for instance: 
Underestimated MR volume
 increasing degrees of aortic regurgitation (AR) will increase trans-aortic SV and 
therefore decrease the difference between MV and LVOT SV, leading to an 
underestimation of true MR volume15
 when LVOT velocities are increased due to outflow obstruction (secondary to systolic 
anterior motion of the AMVL or basal septal hypertrophy) or due to flow acceleration 
prior to a stenotic aortic valve, the LVOT VTI increases in accordance with the 
increased LVOT velocities. The increased VTI leads to an overestimate of SV and 
therefore an underestimate of the MR volume
Overestimated MR volume
 the estimate of MV SV is calculated by multiplying the estimated MV annular area, 
not the true MV orifice, by the trans-mitral VTI. Any degree of mitral stenosis results 
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in an increasing trans-mitral VTI and will therefore lead to an overestimation of the 
MV SV. This increases the difference between MV and LVOT SV and consequently 
overestimates the degree of MR15. 
 Any degree of shunting across a ventricular septal defect will reduce the trans-aortic 
SV and will lead to a greater difference between LVOT and MV SV, thereby 
overestimating MR volume
AF
 beat-to-beat variation of the R-R interval with AF will result in differences in SV at 
both sites and therefore variable estimates of regurgitant volume that will not reflect 
the true degree of MR
Regurgitant fraction
As a ratio of regurgitant flow to total ejected volume, MR is considered severe when the 
regurgitant volume exceeds half of the total LV SV. Therefore, when expressed as a 
percentage, a regurgitant fraction (RF) of >50% indicates severe MR29 (equation 7).
Equation 7 – regurgitant fraction 
Regurgitant SV / LV total SV
However, given that the calculation of regurgitant fraction is derived from the calculations of 
MR volume and LVOT SV, its accuracy is limited by the same haemodynamic factors 
mentioned above.  
As already discussed, with normal valvular function the SV through the MV and LVOT are 
equal. Therefore, because MR leads to a greater SV through the MV relative to the LVOT, a 
simple ratio of MV and LVOT VTI, the regurgitant index, can be calculated to estimate MR 
severity; the ratio increasing as MR volume increases, a ratio >1.4 being consistent with 
severe MR. However, as with all measures of VTI, the value is influenced not only by blood 
volume but also: 
 anatomy, such that a larger or smaller mitral orifice or LVOT CSA will alter the ratio 
of VTIs, irrespective of MR severity. 
 any degree of AR will reduce the ratio secondary to an increase in LVOT SV
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 the PW position for trans-mitral Doppler will influence the VTI such that a sample 
position within the ventricle or atrium, rather than at the leaflet tips, will result in a 
lower VTI for the same volume of blood. 
Table 4 - Grading MR severity
Adapted from the ASE table for grading the severity of chronic MR by echocardiography
As previously described, because the regurgitant orifice in secondary MR is elliptical, PISA 
estimations of ROA and MR volume are underestimated when the orifice is assumed to be 
circular. Additionally, severely impaired LV systolic function, often coexistent with 
secondary MR, often fails to generate a total SV great enough for the standard parameters of 
MR to reach the threshold for severe29. Therefore it is important to highlight that the 
threshold for diagnosing severe secondary MR is less than for primary MR. 
Table 5 – Criteria for severe secondary MR
Adapted from the ASE table for grading the severity of chronic MR by echocardiography
Previous BSE guidance for the assessment of secondary mitral regurgitation recommended 
that an EROA >0.2 cm2 and regurgitant volume >30 ml was consistent with severe MR. This 
recommendation was based on evidence that demonstrated an EROA of >0.2 cm2 was 
associated with a worse prognosis in those with secondary MR19. International society 
guidance for the management of valve disease recommends that a cut-off of 0.2 cm2 provides 
greater sensitivity for the detection of severe secondary MR and that a cut-off of 0.4 cm2 
provides greater specificity. However, the BSE decision to adopt a cut-off of 0.3 cm2 when 
accompanied by other specific criteria for severe MR recognises:
a) that EROA and MR volume by PISA method are underestimated when assessing an 
elliptic regurgitant orifice
b) that surgical repair of ischaemic MR with EROA 0.2 – 0.39 cm2 alone was not 
associated with improved outcomes but was associated with greater risk of 
neurological events and supra-ventricular tachycardia
c) incorporates recent published randomised trial data (ref COAPT MITR-FR) with sub-
analysis29
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 Supportive parameters of haemodynamically severe MR
Volume and pressure overload of the LA secondary to severe MR is associated with a 
number of haemodynamic consequences. TTE can help distinguish moderate and severe 
regurgitation by identifying these haemodynamic alterations, these include: 
Mitral inflow (E velocity and E/A ratio): As regurgitation becomes more severe, the amount 
of blood ejected into the left atrium during systole increases, leading to raised left atrial 
pressure1. Therefore, mitral valve opening in early diastole results in a higher early diastolic 
flow velocity (E wave velocity >1.5 m/s) and an increasingly higher E/A ratio15 (Table 8, 
image 24). However, it is important to note hyperdynamic circulation, mitral stenosis (even 
minor degrees) and LV diastolic dysfunction can also increase E wave amplitude. 
Conversely, if the A wave is dominant (E/A ratio <1), severe mitral regurgitation is virtually 
ruled out. Thus, the interpretation of E/A ratio for the assessment of MR severity has greatest 
sensitivity when a reversed E/A ratio is expected as normal LV filling for age (elderly 
population) 
Pulmonary Vein Flow: Under normal circumstances, blood flows from the pulmonary veins 
(PV) into the left atrium throughout most of the cardiac cycle, with the exception of the atrial 
contraction period when a small volume of blood is ejected back into the PV1 (PVa). As 
mitral regurgitation becomes more severe, the associated rise in left atrial pressure increases 
the resistance to forward blood flow from the pulmonary veins during systole, leading to 
reduced (blunted) systolic pulmonary vein flow. With severe regurgitation, LAP is high and 
blood is forced back into the veins during systole (reversed systolic pulmonary flow)30 (Table 
8, image 27).
Assessment in atrial fibrillation
The increasing prevalence of AF and its close association with valve disease, particularly MV 
disease, has resulted in a growing number of patients in AF undergoing TTE. However, due 
to the persistent variation in cardiac cycle length, measures of ventricular systolic and 
diastolic function may have limited reliability if appropriate measurement guidelines are not 
followed. Although previous versions of the BSE Minimum Dataset guidelines have 
recommended that measures are averaged over 5-10 beats when the heart rate is between 60 
and 80 beats per minute (bpm)17, more recent findings suggest that when preceding and pre-
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preceding RR intervals are within 60 milliseconds (ms) of each other and both exceed 500 
ms, measures of systolic function on a single beat are similar to those averaged over 15 
cycles of varying durations18. These findings suggest that selection of beats with similar RR 
intervals is more important for reproducibility than the total number of measures made. It is 
therefore recommended that the same methodology is applied when performing measures of 
cardiac size and function and of MR and MS severity.
Considerations for mitral valve intervention
Surgical intervention
In primary MR, no specific medical therapy has been shown to alter its natural history. Once 
MR becomes severe, the onset of symptoms or signs of LV impairment are class I indications 
for surgical intervention (repair or replacement) to improve outcome6. However, if surgical 
repair can be performed prior to symptom or LV dysfunction onset, the surgical outcomes 
have been shown to potentially restore normal life expectancy. Therefore, timing of 
intervention prior to this deterioration, but where the balance of surgical risk and likelihood 
of a durable valve repair (the preferred option since it preserves ventricular function and 
carries a lower long-term risk of complications when compared to MV replacement6) is 
considered favourable and early surgery may be considered19. Consequently, a number of key 
echocardiographic findings are essential for determining the appropriate timing of 
intervention in primary severe mitral regurgitation. These should be routinely highlighted in 
the conclusion of all echocardiogram reports when performing an assessment of severe 
primary MR. 
Table 6 – Echocardiographic indications for MV surgery19
In mitral valve prolapse, the likelihood of repair decreases as valve lesion complexity 
increases19. Although surgical repair has demonstrated good long-term durability with more 
straightforward lesions such as isolated P2 prolapse15, increasingly complex lesions (ranging 
from P1 or P3 lesions to isolated anterior to commissural and bileaflet disease6) require 
greater surgical expertise and may be less durable. The presence of extensive leaflet or 
annular calcification may preclude a surgical repair. Extension of annular calcification into 
the basal LV myocardium increases the surgical complexity and should be described within 
the report. 
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Below are listed key primary MR echo descriptors and measures that are useful when 
describing the mechanism of mitral regurgitation and assessing MV reparability 
 Leaflet coaptation - the point where the anterior and posterior leaflets meet to form a 
competent valve.
 Leaflet coaptation zone - the degree of leaflet overlap at the point of coaptation, should be 
> 5mm for a competent valve.
 Leaflet prolapse - where there is excessive leaflet motion and displacement of the tip of 
one or more segments of the mitral valve by 2 mm relative to the hinge points of the 
leaflets,
 Flail leaflet segment - where the free edge (tip) of the leaflet has lost its support through 
chordal rupture of a primary chord(s), resulting in aversion of the leaflet tip into the LA. 
 Leaflet thickness - normal thickness is <5mm, measured in diastole. Increasing leaflet 
thickness correlates with less durable valve repairs.
 Leaflet length - the anterior leaflet length is normally greater than the posterior in the 
normal MV. When the posterior leaflet length is similar or greater than the anterior leaflet 
length there is an increased risk of LVOT obstruction from systolic anterior leaflet motion 
into LVOT.
Mitral annulus – normal size at end systole commissural diameter (in TTE apical two 
chamber or TOE 500 (Fig 8)) and anteroposterior diameter (TTE parasternal long axis view 
(table 1, image 3) or TOE 1350 (Fig 8). 
o AP diameter men <38 mm; women <36 mm; indexed <20.3 mm/m2
o IC diameter men <46 mm; women <42 mm; indexed <24.4 mm/m2
Aorto-mitral angle – the angle between the AV and MV annular planes has been shown to 
correlate with the risk of systolic anterior leaflet motion (SAM) with LVOT obstruction post 
MV repair. An angle <135 degrees and typically below 120 degrees has the potential risk of 
this complication. This is often exacerbated by a long posterior leaflet, which if not addressed 
at the time of repair can result in displacement of the coaptation line towards the LVOT and 
resultant SAM.
Mitral valve surgery (repair or replacement) has not been shown to confer survival benefits in 
secondary MR, although it may improve symptoms and quality of life15. Surgery is therefore 
usually reserved for those who are undergoing concommitant revascularisation and have severe 
secondary MR or have symptomatic severe secondary MR, despite optimal medical therapy 
(+/- Cardiac Resynchronisation Therapy if indicated) and who are considered low risk for 
surgery15.
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Echo considerations prior to repair surgery in secondary MR
Unfavourable characteristics for surgical repair in secondary MR include24:
 Leaflet tenting height >10mm (Table 9, image 3)
 Leaflet tenting area >2.5-3cm2 (Table 9, image 4)
 Interpapillary muscle distance >20mm (Table 9, image 5)
 Global LV remodeling LVEDD 65mm, LVESD 51mm, ESV >140 ml
 Systolic sphericity index >0.7 (Table 9, image 6)
Transcatheter Intervention
For those where surgical intervention (both primary and secondary MR) is contra-indicated 
or too high risk and who remain symptomatic despite optimal medical therapy, transcatheter 
approaches such as MitraClip may improve symptoms29. However, certain anatomical 
parameters may preclude MitraClip on the basis of poor outcome or the development of MS. 
In the case of primary MR, unfavourable parameters include a large flail gap, large flail width 
or small MV orifice <4cm2. In secondary MR, additional emphasis is given to the degree of 
LV dilatation and adverse remodelling along with adequate posterior leaflet length (Table 7) 
Table 7 – Unfavourable parameters for percutanous MV repair
 
Effect on left heart chambers
LA volume
The assessment of LA size is an important element in the investigation of mitral 
regurgitation1,15. LA dilatation secondary to volume overload is an expected finding in those 
with chronic severe MR. Normal LA volume therefore rules out chronic severe MR with near 
certainty31. However, LA dilatation is a common finding in a number of other disease states 
and therefore cannot confirm severe MR. Estimation of LA volume by Simpson’s biplane 
method is recommended (Table 8, images 31-32). However, given the rapid onset, acute 
severe MR may be associated with little or no chamber dilation or adverse remodelling. 
LV size and function
Severe chronic primary mitral regurgitation increases LV preload and will eventually lead to 
chamber dilation, eccentric hypertrophy and ultimately impaired function2, all identify a 
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suboptimal prognosis19. Assessment of LV size and systolic function helps identify the 
optimum timing of intervention. Simpson’s biplane method provides an estimate of both 
diastolic volume (with indexing to BSA) and systolic contractile function (LVEF) and are 
crucial for the effective surveillance of patients with mitral regurgitation, these parameters 
should therefore be performed in all cases where image quality permits7 (Table 8, images 28 
a-b). However, regional variations in chamber geometry and regional wall motion 
abnormalities limit the accuracy of this two-plane measure of a 3D structure. Given its 
improved accuracy, 3D estimates of chamber volume and function are recommended for the 
assessment and surveillance of chamber size, function and adverse remodelling (Table 8, 
image 29). In those with primary severe MR, an LVEF <60% is suggestive of impaired 
systolic function19. 
The assessment of diastolic function can be extremely challenging in patients who have 
coexistent severe MR due to the increase in LA pressure. Although the routine parameters 
measured as part of the diastolic assessment are very likely to suggest moderate or worse 
diastolic impairment when severe MR is present, because of the raised LAP, it is 
recommended that non-standard measures are performed when an assessment of diastolic 
function is necessary32 (see recently published diastolic guidelines). 
Effects on right heart chambers
Pulmonary Artery Pressure and Right heart Assessment
Increases in left atrial pressure secondary to severe mitral regurgitation translate to increased 
pulmonary artery capillary wedge pressure and therefore systolic pulmonary artery pressure 
(SPAP)33. Estimating SPAP by echocardiography is important in patients with severe MR to 
ensure the appropriate timing of intervention. Secondary effects on right ventricular (RV) 
function and progressive secondary tricuspid regurgitation (TR) can also be seen. 
Concomitant primary tricuspid valve disease, while less common, may occur with 
degenerative or rheumatic valve lesions34. Hence it is essential to note RV size, function, TR 
severity, mechanism and aetiology in addition to PAP estimation1,34.
Acute Severe Mitral Regurgitation
Acute severe MR can result from either primary or secondary causes. Primary causes include 
leaflet perforation or destruction secondary to endocarditis, leaflet prolapse secondary to 
chordal rupture (because of either myxomatous valve degeneration or trauma) and papillary 
muscle rupture due to myocardial ischaemia (Table 2). Secondary acute MR is usually caused 
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by ischaemia of the infero-lateral wall leading to regional wall motion abnormality with 
papillary muscle dysfunction and restricted MV closure (tethering) of the posterior leaflet. 
Since the onset of MR is acute, the sudden increase in volume results in a rapid and 
significant increase in LAP with no immediate change in the chamber size (non-compliant). 
Hence acute severe MR may be associated with a normal LA size. The significant increase in 
LAP will result in a rapid rise in pulmonary venous pressure and may result in acute 
pulmonary oedema and may progress to cardiogenic shock.
Special patient group
Barlow’s MV disease is characterized by excessive myxomatous leaflet tissue, along with 
annular dilation, leaflet thickening, bileaflet prolapse and chordal lengthening35. Due to the 
dynamic process of prolapse through systole, the MV remains competent until the point at 
which prolapse causes loss of apposition, typically in mid to late systole. Therefore, when 
non-holosystolic MR is present, the regurgitant volume is lower than the single-frame CF 
Doppler appearance suggests1. Furthermore, significant prolapse of the MV leaflets results in 
traction via the chordae of the papillary muscle. Papillary muscle wall stress is increased as a 
consequence of systolic traction and has been proposed as the cause of papillary muscle 
fibrosis (and additionally basal inferolateral wall) in such patients35 
Mitral annular disjunction (MAD) has been proposed as a potential risk factor for sudden 
cardiac death (SCD) in patients with mitral valve prolapse. It is identified as separation 
between the posterior mitral valve leaflet hinge-point and the ventricular myocardium, 
ensuring that the distance of the ‘muralised’ posterior leaflet base at end-systole is not 
interpreted as the distance of MAD (Table 8, image 4). This is often accompanied by late 
systolic peaking of the lateral wall S’ signal with systolic curling motion of the basal 
myocardium. However, recently published data suggests that this observed phenomenon is 
not unique to MVP, indeed it has been described in patients with ventricular arrhythmias but 
without MV disease36. Furthermore, a very recent publication has described MAD in a series 
on normal hearts using computerised tomography37. At the current time, it appears MAD is 
likely to be a normal finding, where it is the extent of disjunction rather than its presence 
which may be important38. Further studies are needed.
 
Due to the association with ventricular arrhythmias and SCD, the presence of Barlow’s MV 
should be described in the report conclusion. 
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Novel imaging techniques in the assessment and surveillance of MR
While not advocated for routine clinical practice or recommended within international 
guidance for the timing of mitral valve intervention, the emerging and novel parameters 
described below are of growing interest in the assessment of mitral valve disease and may, 
when considered in the clinical context, prompt more careful consideration of surveillance 
frequency.
Global Longitudinal LV Strain 
The application of strain imaging is becoming more widespread and has increasing clinical 
utility in echocardiographic practice, speckle-tracking derived strain being the most 
commonly utilised method7 (Table 8, image 30). Unfortunately, there remains significant 
inter-vendor variability, such that a single reference interval would not suffice for all 
practitioners. Additionally, it is not clear whether different versions of strain software provide 
comparable results. Individual vendors currently provide reference intervals for specific 
platforms and software versions. However, strain tools are of value when used sequentially 
on a single individual in order to help identify subclinical interval changes in LV 
performance7. Therefore, GLS may be helpful in identifying subclinical LV dysfunction in 
the setting of serial echocardiograms and may help determine appropriate follow-up intervals 
or timing for intervention39.
LA function analysis
Normal left atrial function is a key contributor toward normal cardiac output. LA function is 
divided into three phases, each of which is characterized by specific functional capabilities. 
The reservoir phase reflects LA expansion during ventricular systole, and describes the 
ability of the atrium to ‘absorb’ pulmonary venous return. The conduit phase occurs 
immediately after mitral valve opening, and describes early diastolic atrial emptying 
(corresponding with the E wave on the mitral Doppler wave form), combined with diastolic 
pulmonary venous return. Although frequently considered a passive phenomenon, early 
diastolic emptying of the LA is contributed to by elastic recoil of the normal LA. Finally, the 
contractile phase represents active atrial emptying or contraction and corresponds with the 
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MV Doppler A wave and the p-wave on the ECG. When sinus rhythm is lost, there is no 
contractile phase, and reservoir and conduit phases are of equal magnitude. 
There are two main methodologies by which atrial function can be assessed. The volumetric 
method involves the measurement of LA volume at different time-points of the cardiac cycle, 
from which the three phases of atrial function can be derived. This approach is somewhat 
time-consuming and is not practical for busy echo departments, although the assessment of 
the ‘total left atrial emptying fraction’ (TLAEF), which is synonymous with the reservoir 
phase, can be obtained relatively easily from the maximal and minimal LA volume using the 
following formula40:
Equation 8 – LA emptying fraction
(maximal LA volume – minimal LA volume) / maximal LA volume
The second method utilizes speckle strain imaging.  All three phases of LA function can be 
obtained from focused 2D images of the LA. The BSE recommended technique for obtaining 
LA strain indices is demonstrated in Figure 5, and has a large published evidence-base40,41,42. 
It is important to appreciate that although a negative strain value is conventionally assigned 
to phases in which myocardial fibres reduce in length (i.e. during contraction), the 
overwhelming majority of studies of atrial strain, including recently published normative 
reference intervals from the NORRE dataset, describe all three phases of LA function as a 
positive value41,42. 
LA function indices are particularly useful when assessing patients with chronic MR 
secondary to primary mitral valve disease. LA strain reflects the severity of mitral 
regurgitation, alterations in LV systolic and diastolic function, increases in PA pressure and 
the presence of cardiovascular symptoms44,45. As such, in moderate and severe MR there are 
only minor reductions in reservoir and contractile strain, but in patients with a guideline 
indication for MV surgery, LA function is markedly reduced, almost certainly as a 
consequence of interstitial fibrosis developing within the LA myocardium44,46,47. In 
prospective studies, reductions in reservoir strain are associated with poor cardiovascular 
survival, increased likelihood of AF during follow-up, or the development of a guideline 
indication for cardiac surgery46,48-50. 
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In asymptomatic patients with moderate to severe MR and no guideline indication for mitral 
valve surgery, a TLAEF <51%, or reservoir strain <29% may be useful in identifying those 
patients in whom early surgical intervention may be indicated, or at least identifying those 
patients who may benefit from increased frequency of follow-up49. 
Figure 5 – LA deformation analysis
Proportionality of MR 
Unlike chronic severe primary MR where adverse LV remodeling may be caused by the MR, 
secondary MR typically develops as a consequence of LV disease and dysfunction29. 
Therefore, treatment strategies are directed towards the underlying LV disease process15. 
However, difficulties have arisen when attempting to decipher which group of patients may 
or may not benefit from mitral valve intervention20. The degree of MR (EROA) in the context 
of the degree of adverse LV remodeling may therefore provide useful insight into the 
haemodynamic significance of MR and its contribution to LV dilatation50. When the LV is 
severely dilated and with severely impaired systolic function, a large EROA and RF reflect a 
degree of secondary MR that is proportionate to the degree of LV dilation. However, less 
severe LV dilatation with a similarly large EROA and RF may indicate a degree of MR that 
is disproportionate to the degree of LV dilatation alone20. This latter group have been shown 
to benefit from MR reduction via transcatheter intervention (fig 6) 51. Therefore, parameters 
quantifying LV size to the proportion of MR may identify those who will benefit most from 
such therapies. Although not yet established in routine clinical practice, an EROA:LVEDV 
ratio of 0.14 (mm2/ml) may differentiate between those in whom medical therapy should be 
optimised and those who may be considered for transcatheter therapy.
Fig 6 – Proportionate vs disproportionate MR
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Key Points for the assessment of MR
 Consider the anatomical findings that are consistent with severe MR
 PISA estimates of MR parameters assume perfect hemispherical PISA geometry. As 
this is rarely the case, especially in the setting of secondary MR, PISA estimations 
should always be considered alongside other indicators of MR severity
 The assessment of MR volume and MVA by the continuity method is limited through: 
multiple measures required to perform calculations of valve area and regurgitant 
volume, the assumptions of anatomical geometry necessary when making calculations 
and the presence of other valvular or congenital pathology that alter LV and/or MV 
SV. 
 VC measured by CFD is an effective measure of regurgitant orifice area and therefore 
MR severity, with particular strength in eccentric jets.
 Consider the haemodynamic indicators that suggest MR is severe or non-severe
 Novel indicators of MR severity may provide useful insight in the surveillance of 
patients with MR
Table 8 - Guide to 2D image acquisition in mitral regurgitation
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Table 9 - Characteristics that identify unfavourable outcome to MV repair surgery
MITRAL STENOSIS
Despite the declining incidence of rheumatic fever in industrialised countries over the past 40 
years, the most common cause of mitral stenosis (MS) remains rheumatic disease15. Although 
other aetiologies of MS exist, including post-inflammatory processes such as Systemic Lupus 
Erythematosus (SLE) or Rheumatoid Arthritis; radiation induced valve disease; significant 
annular calcification; congenital abnormalities and mechanical obstruction by tumour or 
thrombus, these aetiologies and mechanisms are rare and constitute a very small percentage 
of those presenting with clinically significant mitral stenosis. Commissural fusion (with 
thickened rolled free edges) is the hallmark of rheumatic valve disease. With the aging 
population, the incidence of calcific (degenerative) MS is increasing and poses challenges to 
assessment. The stenotic orifice is more planar (rather than funnel shaped as in rheumatic 
MS) and haemodynamic assessment may be discrepant with Doppler measures1.
When MS is suspected, trans-thoracic echocardiography remains the primary imaging 
modality for the evaluation of probable aetiology, lesion severity and to help determine the 
appropriate interventional technique. Consequently, a complete assessment of the stenotic 
MV does not focus solely on mitral valve area and trans-valvular gradients, but also considers 
sequelae, including MR, valve anatomy and chordal involvement, concomitant aortic valve 
disease, LA size and pressure, pulmonary pressures and right heart size and function15.
Aetiology and mechanism
The initial assessment of the valve is a visual examination of the degree and distribution of 
thickening, fibrosis and/or calcification, along with the extent and appearance of leaflet 
mobility. Although the valve should be assessed in both the parasternal and apical windows, 
valve anatomy and degree of leaflet restriction are best appreciated in the long and short axis 
parasternal windows.
Characteristic 2D features in those with rheumatic mitral stenosis include:
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 Leaflet fibrosis and thickening that is predominantly confined to the tips and 
commissures (mitral valve calcification tends to spare the leaflet tips). Thickening 
comes first with calcification later (Table 12, images 1 and 6)
 Chordal thickening, fusion and shortening
 Relative mobility of the leaflet base in comparison to leaflet tips. In rheumatic disease 
the tips and commissures tend to be fused and restricted so that the valve appears to 
‘dome’, this is also referred to as a ‘hockey stick’ or ‘elbowing’ appearance (Table 9).
 Evidence of commissural fusion demonstrated in the PSAX or 3D views (Table 12, 
image 6)
Grading mitral stenosis severity
Mitral valve stenosis severity is described by the mitral valve area (MVA) and the mean MV 
gradient (MG). Indirect estimates of MVA are based on measures of transvalvular Doppler 
profiles and are therefore influenced by both loading conditions and coexistent valvular 
disease1. 
Heart rate (HR) and rhythm
Since all Doppler based estimates of MVA and MG are influenced by HR and rhythm, these 
should be routinely reported. For the surveillance of MVA and MG, variations in HR and 
rhythm should be excluded as the cause of any interval changes in these parameters. When 
the patient is in AF, estimation of MVA and MG should be avoided during extremes of HR 
and R-R interval. It is recommended that parameters are calculated on the basis of averaged 
measures from five beats or from measures made on R-R interval matched beats (see BSE 
Minimum Dataset). 
Trans-mitral pressure gradient
As mentioned previously, reduced MV opening secondary to intrinsic leaflet restriction 
prevents complete LA diastolic emptying and eventually leads to increased LA volume and 
consequently pressure overload1. The relationship between LA pressure and MVA is 
therefore inverse, where a decrease in MVA increases LAP. Thus, when cardiac loading 
conditions and both LA and LV compliance are normal, the LA-LV pressure difference is 
proportional to the degree of valvular stenosis and can be considered a good indicator of MS 
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severity1. In this setting, MS is considered mild when the mean transvalvular gradient is less 
than 5 mmHg and severe when exceeding 10 mmHg15. However, the mean transvalvular 
pressure gradient is significantly influenced by alterations in loading conditions, including 
changes in LA and LV diastolic pressures. Due to load and flow dependency, mean trans-
valvular pressure gradient is not a good indicator of MS severity where cardiac disease 
coexists, particularly in the presence of AF. Increases in LV diastolic pressure in the presence 
of aortic regurgitation (typically moderate or more) and/or LV diastolic dysfunction reduces 
the LA-LV pressure difference. This results in a reduction in the mean pressure difference 
and therefore measured gradient1. Conversely, moderate or more MR will increase LA 
pressure and further increase the LA-LV pressure difference, thereby increasing the mean 
pressure gradient1.
Mitral Valve Area: methods and limitations
The essential measurement for the diagnosis of MS severity is the estimation of MVA. It can 
be measured directly by tracing the anatomical orifice area using 2D or 3D imaging (direct 
planimetry) or indirectly through measures of transvalvular Doppler profiles (P½t, continuity 
and PISA)1,15. Since planimetry is a direct measurement of the stenotic orifice it is less 
influenced by loading conditions compared to other estimates of MVA. Hence it is 
considered the reference standard for area measurement and grading of MS severity12. 
Planimetry 
2D planimetry: 2D planimetry of the MV orifice is performed in the PSAX view of the MV 
with careful angulation and tilting of the beam to ensure imaging of the leaflet tips (Table 12, 
image 6). The image is frozen and scrolled through until the point of maximal valve opening. 
Image optimisation is achieved by reducing sector width and scan depth to increase temporal 
resolution, or applying 2D zoom to increase both temporal resolution and image size1,15. 
Image gain and compression are optimised to avoid ‘flaring’ of the leaflet tips and ensure 
distinct definition of the blood-tissue interface. If not optimised and the image over-gained, 
there is a risk of underestimating MVA and therefore overestimating the degree of MS 
severity. Conversely, the MVA may be overestimated if the scanning plane is not aligned en-
face with the orifice and bisects through the body of the leaflets. For this reason, 2D 
planimetry tends to overestimate MVA. Although tracing the CFD contour overlaid onto MV 
orifice is not recommended to estimate MVA, CFD is extremely helpful in identifying the 
position and geometry of the orifice and assist with MVA measurement on the 2D image. 
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3D planimetry: Imaging of the MV can be performed using 2 modes of 3D imaging formats -
biplane imaging and 3D volume imaging. 
Biplane imaging provides simultaneous images from a second scanning plane. Although the 
second imaging plane is usually orthogonal to the primary image, any degree of rotation can 
be applied. When scanning in the long-axis view of the MV, orthogonal imaging in a plane at 
the level of the MV tips can provide an on-axis view of the MV orifice (Table 12, image 7). 
However, for accurate planimetry of the valve area, biplane imaging relies on the MV orifice 
lying parallel to the orthogonal imaging plane.
The advantage of 3D volume imaging is the ability to view anatomy from any perspective 
within the dataset. Cropping the dataset using multiplane reconstruction software allows 
accurate alignment of the imaging plane at the level of the leaflet tips (narrowest point of the 
orifice), providing a truly en-face view of the orifice15 (Table 12, image 8). This method 
avoids the risk of overestimating MVA and therefore under estimating MS severity that is 
associated with 2D planimetry
Pressure half-time
As previously described, when left atrial pressure (LAP) is raised secondary to mitral 
stenosis, the time taken for early trans-mitral velocity to fall by half it’s starting value can 
provide an estimate of MVA1. The high pressure difference between the LV and LA caused 
by MS results in maintained trans-mitral velocities throughout diastole and is reflected by an 
extended time for pressure to fall by half and consequently shallower deceleration of the MV 
E wave (Table 12, image 10). MVA is then calculated by dividing a LV relaxation constant 
value of 220 by the P½t (equation 5) 
However, the rate of pressure decay and the time taken for pressure to fall by half is not 
solely determined by the mitral orifice size and is also influenced by a number of 
physiological and patho-physiological loading conditions that affect intra-cardiac flow and 
pressure15. As these naturally affect the rate of pressure fall, they also alter the P½t and 
therefore the estimate of MVA. For instance, for a given MV stroke volume and MVA, both 
severe aortic regurgitation and reduced LV compliance will increase LV pressure throughout 
diastole, resulting in more rapid equalisation of LV-LA pressure difference and a shorter time 
for pressure to fall by half; the outcome is an overestimated MVA1. Conversely, when LAP is 
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raised further by moderate or severe mitral regurgitation, the half-time for pressure 
equalisation is extended and the MVA underestimated. The P½t is additionally influenced by 
LA compliance (LAC), where the rate of pressure decay decreases as LAC decreases.  P½t 
estimate of valve area is therefore considered the least accurate of the indirect Doppler 
estimates available during TTE.
The rate of E wave deceleration is often more rapid in the early descent than it is in later 
diastole. This results in a bimodal E waveform where the initial E deceleration slope is steep 
before becoming shallower for the remainder of diastole. In this scenario, the P½t estimate of 
MVA should be measured on the shallower second phase of the deceleration slope. In the 
rare scenario of the deceleration slope being curvilinear, measurement may not be possible.  
When the patient is in AF, adequate rate control permits uninterrupted measurement of the E 
deceleration and estimation of MVA by P½t. However, when the patient is in SR, elevated 
HR (>100 bpm) or first-degree AV block results in E/A fusion and truncation of the E 
deceleration slope, therefore preventing accurate measurement of the P½t. In these scenarios, 
estimation of MVA by other methods is recommended.
Continuity equation
Although a recognised method of assessing valve area, continuity estimates of MVA are 
limited by the assumption that SV is equal at both the LVOT and mitral valve sites. Given 
that MVA is calculated as LVOT SV divided by MV VTI, the presence of aortic 
regurgitation increases LVOT SV and therefore results in an overestimated15 MVA. 
Conversely, when mitral regurgitation is present, the SV at the MV level is greater and the 
MVA consequently underestimated and MS severity overestimated. In patients with AF, SV 
varies significantly from beat-to-beat. If a continuity estimate is going to be made in the 
setting of AF, measures should be made during similar R-R intervals. Additionally, because 
of the number of measurements required to estimate MVA by continuity equation, 
measurement error and suboptimal Doppler alignment can lead to inaccurate estimates of 
MVA1.
PISA
Although more commonly used to calculate regurgitant orifice area and volume for mitral 
regurgitation, the PISA method can also be utilised to calculate MVA in those with MS 
(Table 12, image 13). However, the geometry of the regurgitant MV PISA is different to the 
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stenotic MV PISA. Because the atrial surface of the MV is not planar in those with rheumatic 
valve disease, typically being funnel shaped, the PISA geometry is more conical than hemi-
spherical (Table 9) and a correction factor must be applied to account for the overestimation1. 
This correction factor is determined by measuring the angle of the atrial surface of the leaflets 
in diastole. Given that the PISA equation assumes a flow rate and MVA based on a planar 
orifice with a hemi-spherical shell of 180, multiplying the flow rate by the angle of the atrial 
surface of the leaflets divided by 180 corrects for the non-planar geometry and provides a 
more accurate estimate of MVA50 (equation 8). 
Equation 8 – PISA estimate of MVA
This method is of particular value when other Doppler based methods of estimating MVA are 
rendered inaccurate by variable SV (AR, MR and AF), or when LA or LV pressures are 
increased for reasons other than MS (MR and LV diastolic dysfunction). However, the wider 
application of this method is limited by the inability to measure the angle of the MV leaflets 
on many echo machines
Table 10 – Grading MS severity
Adapted from the EAE/ASE table for grading the severity of MS by echocardiography
LA volume
As already discussed, chronic pressure loading of the LA results in adverse remodelling to 
increased LA chamber size. However, increased LA volume may be seen in a number of 
disease processes and does not confirm severe MS in isolation, although normal LA volume 
almost certainly excludes severe MS (Table 8, images 31-32). 
Pulmonary Artery Pressure
Similar to the haemodynamics seen in MR, increased LA pressure secondary to severe MS 
translates to increased pulmonary artery capillary wedge pressure and therefore systolic 
pulmonary artery pressure (Table 8, image 33). Estimating systolic PAP by echocardiography 
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Considerations for intervention and the role of echocardiography
When clinically significant MS is present, appropriate patient selection for intervention relies 
on the aetiology of mitral stenosis and the associated valve anatomy1,19. When the underlying 
cause is post-rheumatic valve disease, percutaneous balloon mitral valvuloplasty (PBMV) 
can be considered. The procedure aims to split the fused commissures thereby increasing 
valve opening. However, when the aetiology is post-radiation/non-rheumatic post-
inflammatory fibrosis or there is diffuse leaflet calcification present, the outcome to PBMV 
may be unfavorable and surgery is preferred. To aid risk stratification, a number of scoring 
systems exist. The most commonly applied is the Wilkins score which assesses MV anatomy 
in terms of leaflet mobility, thickness, calcification and sub-valve characteristics (Table 11). 
The minimum score is 4 and maximum 161. A score < 8 is favorable for PBMV with good 
long-term outcomes, with prolonged freedom from reoperation (15-20 years) and restenosis 
rates. 
Contraindications to percutaneous mitral commissurotomy 
 MVA >1.5 cm2
 LA thrombus
 More than mild MR
 Severe bi-commissural calcification
 Absence of commissural fusion
 Severe concomitant aortic valve disease, or severe combined tricuspid stenosis and 
regurgitation requiring surgery
Table 11 – Wilkins score
Key Points
 2D planimetry overestimates the MVA when the imaging plane is not parallel with 
the plane of the orifice.
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 3D imaging overcomes the limitations of non-parallel 2D imaging and allows the 
operator to view and planimeter the MV orifice at the leaflet tips.
 Continuity estimates of the MVA are limited by the multiple measures required for 
the calculation and by other valvular and congenital pathologies that result in a SV 
mismatch between the LVOT and MV.
 Estimates of MVA by P½t are heavily affected by variations in LA and LV 
compliance, MR (with worsening accuracy as MR severity increases) and increases in 
LV diastolic pressure secondary to either LV diastolic dysfunction or AR. 
 Mean trans-mitral pressure gradient is increased or decreased by other pathologies 




The clinical indications for stress echo in patients with mitral valve disease can be divided 
into two categories: severe valve disease without symptoms and non-severe disease with 
symptoms53. In both scenarios, the aims of the test are to determine whether the patient is 
symptomatic or if valve disease is truly severe and therefore requires intervention. 
Exercise can be performed by either upright-treadmill or semi-supine bike. When stress is 
performed by treadmill, images are acquired at baseline and immediately post stress (within 
90 seconds of exercise cessation) in the left lateral decubitus position1,53. When performed by 
semi-supine bike, images are acquired at baseline, low workload and peak stress50. The 
protocol chosen should reflect the patient’s physical capability and should allow them to 
achieve their maximum exercise capacity. For those who are physically able and are not 
significantly limited by symptoms, the Bruce protocol can be undertaken on the treadmill or 
the WHO protocol (two minute increments of 25 or 50W increments) on the semi-supine 
bike. However, for those who are significantly limited by symptoms or who have limited 
physical capability, a modified-Bruce or Naughton protocol may enable greater exercise on 
the treadmill, or a protocol of 10W increments at two minutes on the bike.
Although the primary investigation is to clarify the severity of MR or MS, coexistent heart 
disease that may contribute to or account for symptoms should also be excluded. Assessment 
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of coronary artery disease and regional wall motion abnormalities should be performed at 
peak stress while an assessment of diastolic function and filling pressures should be made at 
lower HR in those with no more than moderate MR or MS1. 
The assessment of diastolic function during semi-supine bike exercise is performed at HR 
around 100-105 bpm, or before fusion of E/A and e’/a’ signals. Because images cannot be 
acquired during treadmill exercise, measures of diastolic function should be taken during the 
recovery period when the HR has fallen to 100 bpm or when E/A and e’/a’ fusion is no 
longer present. Normal myocardial function is identified by augmentation of both systolic 
and diastolic parameters during exercise. Although E velocity increases during stress in 
normal subjects, there is a proportional increase in e’ that maintains a normal E/e’ ratio. 
However, when exercise reveals diastolic dysfunction and raised filling pressures, e’ 
parameters do not increase with the same proportionality as E velocity and an increase in E/e’ 
is seen. An increase in E/e’ >14 during exercise indicates diastolic dysfunction with raised 
filling pressures51. If severe MR or MS is present at baseline, mLAP and trans-mitral 
velocities are likely to be high and the E/e’ consequently raised, the exercise assessment of 
diastolic function cannot be performed in this setting. 
Primary mitral regurgitation 
When primary MR is at least moderate and the patient is symptomatic, stress echo can help 
identify the following haemodynamic and functional responses to exercise that are known to 
be associated with poor long-term outcomes: 
 Increase in MR severity by >1 grade 
 Dynamic PH (>60 mmHg) 
 Limited LV contractile reserve (LVEF augmentation <5% or GLS <2%) 
 Limited RV contractile reserve (TAPSE <18 mm)53
When resting MR is not severe, the stress echo image acquisition sequence should include 
and be in the order of:
 CFD for post-processing of PISA and VC
 MR CW for PISA quantification
 TR velocity to assess SPAP
 Standard LV views to assess for regional/global impairment51
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Assessment of TR velocity should also be made early during exercise since early increases in 
SPAP are indicators of more significant disease53
Secondary mitral regurgitation 
When MR is secondary, stress echo is indicated to compare exertional symptoms with 
baseline parameters and dynamic changes with exercise. Current guidelines recommend that 
stress echo for the assessment of secondary MR is indicated in the following scenarios53: 
 When resting LV systolic function and degree of MR are disproportionate to the 
degree of symptoms 
 Following recurrent and unexplained episodes of pulmonary oedema 
 To assess moderate MR prior to already planned coronary artery bypass grafting to 
identify those would benefit from dual CABG and MV surgery 
 Persistent PH following MV repair surgery 
The following findings are associated with worse prognosis: 
 Increase in severity as identified by increase in EROA by >13 mm2
 Dynamic PH (>60 mmHg)
Mitral Stenosis 
Stress echo is useful for assessing the haemodynamic significance of mitral stenosis and is 
recommended in both severe asymptomatic and non-severe symptomatic settings. Although 
exercise echo is primarily for the assessment of symptom development, the echo measures 
acquired during exercise stress echo are: 
 CW MV for Mean Pressure Gradient
 MVG >15 mmHg with exercise
 CW TR for estimate of SPAP 
 SPAP >60 mmHg. 
When the MVA is <1.5 cm2 but >1 cm2, stress echo is indicated for the 
planning of pregnancy or major non-cardiac surgery irrespective of suitability of PBMV. 
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Severe asymptomatic MS: When the MVA is <1 cm2 but the patient remains asymptomatic, 
exercise stress echo is recommended to assess for the development of symptoms. When 
MVA is <1.5 cm2 and BMV is feasible, exercise stress echo is recommended to unmask 
exertional symptoms or assess for indicators of haemodynamically significant MS
Symptomatic non-severe MS: The primary indication for exercise stress echocardiography in 
those with symptoms and non-severe MS is the assessment of exertional symptoms in the 
context of the simultaneous haemodynamic findings. MS is severe when the markers above 
are satisfied. A significant SPAP raise during exercise is typically seen early and is associated 
with the development of exertional symptoms. Therefore, this parameter should be carefully 
assessed in the early stages of exercise53.
Table 12 - Guide to image acquisition in mitral stenosis
TRANSOESOPHAGEAL ECHOCARDIOGRAPHY (TOE)
TTE is the first line in the assessment of MV disease. Where echo windows are limited, or 
further clarification in aetiology, mechanism and reparability of the valve lesion is needed, 
TOE offers high resolution imaging (since the probe lies closer to the MV, without 
interference from lung or chest wall). TOE allows comprehensive assessment of the valve 
anatomy and both regurgitant jet and stenotic orifice characteristics9. If interventions such as 
MV repair or percutaneous mitral commissurotomy is contemplated then TOE provides 
essential morphological data to guide patient selection. It is essential to be aware of the 
potential haemodynamic changes in the fluid depleted sedated patient and the consequences 
on mitral valve assessment. This is particularly relevant in MR where its severity can be 
underestimated. Blood pressure and heart rate are therefore essential considerations when 
investigating MR and should always be recorded. 
TOE protocol
A systematic approach is encouraged. The key imaging planes include oesophageal views at 
0°, 50°. 90°, and 1350 and trans-gastric views at 0° and 90°. However careful observation 
throughout the changing probe angles ensures all pathology is correctly identified. Probe 
angles given are guidance only and the anatomical structures are the focus when optimizing 
each view. Landmarks are essential in identifying structures (aortic valve- adjacent to anterior 
leaflet, left atrial appendage identifies lateral portion of valve P1/A1/ALC, inter-atrial septum 
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(IAS) identifies medial portion of MV, typically P3/A3)9. Each view is performed with and 
without colour Doppler, simultaneous 2D only and 2D with CF Doppler imaging is 
recommended to gain a full appreciation of anatomy and flow. Additionally, and where 
appropriate, PWD and CWD (see TTE section for further details) can provide further 
information.  3D echo imaging provides additional functional anatomy. 3D colour helps to 
locate the regurgitant jet and describe the precise location and extent underlying lesion(s).
Views and corresponding anatomy (see figure 1)
 0° - five chamber mid-oesophageal (ME) view: may require slight flexion of the 
probe to open the LVOT, the LV is foreshortened in this view. This view is an oblique plane 
across the MV, segments viewed A2 and P2-1 
 0° - four Chamber ME view: the probe is retroflexed to visualize the true LV apex, 
the LVOT is closed off and the image is centered on the MV. This is an oblique plane 
through then MV, segments viewed are typically A2-1 and P1.  A sweep of the MV segments 
can be performed by advancing the probe slightly to view A2-P2 and further still A3-P3 
(high/mid/low oesophageal views) However note the views are oblique planes through the 
valve and not perpendicular to the coaptation line. These views give a useful overview of 
lesions and their location. Further confirmation is then required through rotation of the plane 
angles as described below.
 50° - ME commissural view. This is a plane through the entire coaptation line with 
P3, A2, P1 segments usually in view. LAA is usually partially in view where P1 is adjacent. 
Rotation of the probe right/left will identify the extremes of the valve, the commissures 
(towards LAA -ALC is seen).
 90° - ME view usually allows a image plane through P3 and all 3 segments of the 
anterior leaflet, A3-2-1. The LAA locates the lateral aspect of the valve (A1). 
 135° - ME long axis view is optimized to open the LVOT and transect the AV/aorta. 
The central portion of the MV is seen A2 (nearest AV) and P2.
 0° - Trans-gastric (TG) view. By advancing into the stomach, the probe is flexed (may 
also require slight rotation of the probe itself) and the LV in short axis is viewed. The MV is 
brought into view by further flexion of the probe. All 6 segments and commissures can be 
viewed with this en face view of the valve seen from the LV surface. The probe can be 
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gradually retroflexed, sweeping through the LV in short axis from base (MV level) through to 
PMs and apex. The subvalvular apparatus can be studied.
 90° - TG view. From the 0° TG view, the probe angle can be rotated and the long axis 
of the LV with inferior wall nearest and anterior wall furthest from the transducer. To 
optimize the view and bring both PMs and chordal structures/MV into view probe may 
require slight rotation. LA lies to right of screen.
3D transoesophageal echocardiography
3D echo is particularly useful for elucidation of aetiology and mechanism. 3D echo provides 
a clear depiction of the functional anatomy giving an enface ‘surgical view’. All segments of 
each leaflet, commissures and annulus can be viewed in real-time, immediately locating the 
lesion(s), site of regurgitation (3D colour) and extent of disease. Dedicated software allows 
detailed analysis of leaflets and annulus, particularly useful in mitral valve repair planning. 
The standardised method of viewing the MV is from the left atrium similar to the surgeon ‘s 
view, hence the name MV surgical view. 
Fig 7 – TOE imaging planes
In mitral regurgitation the TOE study should define the underlying mechanism to assist 
planning mitral valve intervention, see TTE section for echo descriptors (Fig 8). TOE is 
particularly useful in accurately visualizing the regurgitant jet and its components. Higher 
transducer frequencies and integration of multiple views result in more reliable measurements 
of both vena contracta and PISA. However, the different transducer frequency, pulse 
repetition frequency, and gain may cause these parameters to appear slightly larger on 
transoesophageal images than transthoracic images.
Fig 8 – 3D CFD assessment of the MV
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In mitral stenosis, the TOE study should assess not only the orifice area using methods 
described in the TTE section, but in addition assess for the presence and severity of 
concomitant MR. 2D Planimetry, performed in the trans-gastric 0° view, provides a short axis 
‘fish mouth’ view of the mitral valve. The probe level is optimized to ensure alignment with 
the leaflet tips, identifying the maximum opening in diastole. 3D TOE assessment of the 
stenotic orifice has become the reference modality for MVA quantification. Planimetry of the 
mitral valve orifice can be performed using 3D imaging whereby multiplane reconstruction 
software can align precisely with the narrowest portion of the MV orifice (usually at the 
leaflet tips), see table 9. Multiplane reconstruction software allows accurate identification of 
the stenotic orifice which can then be traced to describe the valve area. For details of TOE 
assessment for percutaneous MV commissurotomy see mitral stenosis section ‘considerations 
for intervention’.
CONCLUSION
The role of echocardiography in mitral valve disease assessment has expanded rapidly over 
recent years, including advances in image quality and newer techniques such as 3D 
echocardiography, strain imaging and stress echocardiography. As interventional techniques 
both surgical and transcatheter continue to evolve, echocardiography will continue to play a 
critical role in diagnosis, patient selection and guidance during interventions in this disease 
entity as well as post intervention follow up. Therefore, a precise understanding of mitral 
valve disease necessitates a systematic approach and should encompass a description of 
aetiology, mechanism, severity and haemodynamic consequences. Detailed guidance on how 
to acquire, describe and quantify relevant parameters has been summarised in this document.
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Figure legends 
Fig 1. Mitral valve anatomy - ventricular surface
Fig 2. Schematic on the left demonstrates the PISA at a Nyquist limit of 50 cm/s, any velocity 
exceeding this will alias and be assigned a colour representative for the opposite direction. 
The schematic on the right demonstrates the PISA at a Nyquist limit of 40 cm/s. This 
increases the size of the PISA being imaged and improves measurement accuracy
Fig 3. Mechanism of MR is described in terms of leaflet motion. The top diagram depicts 
normal leaflet function in systole in a competent mitral valve. Carpentier’s classification 
categorises this concept into three types. Type 1 normal leaflet motion with annular dilatation 
and increasing loss of coaptation as the two leaflets are pulled apart. Type 2 excessive leaflet 
motion where there is prolapse of redundant tissue above the level of the MV annulus into the 
LA, or when, due to the loss of primary chordal support, the tip of the leaflet everts and 
‘points’ into the left atrium, called flail. Type 3 describes reduced leaflet motion, termed 
leaflet restriction. This can be due to primary leaflet disease, where the leaflet is shorted due 
to retraction which in turn reduces its ability to move during the cardiac cycle and its reduced 
height limits its ability to coapt correctly with adequate height of coaptation zone (tissue 
overlap/apposition). This is categorised as Type 3a. Type 3b describes leaflets that are 
anatomically normal, but that are tethered due to a disease of the left ventricle. The left 
ventricle is dilated and or there are underlying wall motion abnormalities effecting papillary 
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muscle function resulting in increased tension on the subvalvular apparatus. This in turn leads 
to tethering of the leaflets into the LV and prevents their return towards the annular plane to 
meet the opposite leaflet in systole, with resultant mitral regurgitation.
Fig 4. Diagrammatic illustration of regurgitant jet morphology. The three jet components are 
shown: flow convergence, vena contracta (narrowest portion of the jet as it enters the 
regurgitant orifice and is just distal to the true anatomic orifice), jet expansion into the 
receiving chamber.
Figure 5. LA strain imaging from the LA-focused apical windows. The zero-reference point 
should be marked as mitral valve opening, which usually corresponds to the onset of the QRS 
on the ECG. A typical timePage 37 of 93 echo@bioscientifica.com Manuscript submitted for 
review to Echo Research and Practice For Review Only BSE Mitral Valve Guideline 
deformation curve is displayed (a), with the coloured traces representing the 6 individual 
segments of the LA, and the dotted white trace the average value (or global strain). Reservoir, 
conduit and contractile strain are annotated in image (b). This process should be repeated 
from both the 4- and 2-chamber windows and the average values reported.
Fig 6. Proportionate vs disproportionate MR
Fig 7. TOE imaging planes
Fig 8. 3D CFD assessment of the MV
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Fig 1. Mitral valve anatomy - ventricular surface 
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Fig 2 - schematic on the left demonstrates the PISA at a Nyquist limit of 50 cm/s, any velocity 
exceeding this will alias and be assigned a colour representative for the opposite direction. The 
schematic on the right demonstrates the PISA at a Nyquist limit of 40 cm/s. This increases the size of 
the PISA being imaged and improves measurement accuracy 
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Fig 3. Mechanism of MR is described in terms of leaflet motion. The top diagram depicts normal leaflet 
function in systole in a competent mitral valve. Carpentier’s classification categorises this concept into 
three types. Type 1 normal leaflet motion with annular dilatation and increasing loss of coaptation as the 
two leaflets are pulled apart. Type 2 excessive leaflet motion where there is prolapse of redundant tissue 
above the level of the MV annulus into the LA, or when, due to the loss of primary chordal support, the tip 
of the leaflet everts and ‘points’ into the left atrium, called flail. Type 3 describes reduced leaflet motion, 
termed leaflet restriction. This can be due to primary leaflet disease, where the leaflet is shorted due to 
retraction which in turn reduces its ability to move during the cardiac cycle and its reduced height limits its 
ability to coapt correctly with adequate height of coaptation zone (tissue overlap/apposition). This is 
categorised as Type 3a. Type 3b describes leaflets that are anatomically normal, but that are tethered due 
to a disease of the left ventricle. The left ventricle is dilated and or there are underlying wall motion 
abnormalities effecting papillary muscle function resulting in increased tension on the subvalvular 
apparatus. This in turn leads to tethering of the leaflets into the LV and prevents their return towards the 
annular plane to meet the opposite leaflet in systole, with resultant mitral regurgitation. 
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Fig 4. Diagrammatic illustration of regurgitant jet morphology. The three jet components are shown: flow 
convergence, vena contracta (narrowest portion of the jet as it enters the regurgitant orifice and is just 
distal to the true anatomic orifice), jet expansion into the receiving chamber. 
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Figure 5 Legend: 
LA strain imaging from the LA-focused apical windows. The zero-reference point should be marked as 
mitral valve opening, which usually corresponds to the onset of the QRS on the ECG. A typical time-
deformation curve is displayed (a), with the coloured traces representing the 6 individual segments of the 
LA, and the dotted white trace the average value (or global strain). Reservoir, conduit and contractile strain 
are annotated in image (b). This process should be repeated from both the 4- and 2-chamber windows and 
the average values reported.  
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Fig 7 – TOE imaging planes 
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Fig 8 – 3D CFD assessment of the MV 
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Table 1. MV anatomy and TTE imaging view
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Table 1. MV anatomy and TTE imaging view
Image 5
MV tilting in 








the MV while 
tilting the probe 
towards the RV 
inflow view 
demonstrates 





Focusing on the 
MV while tilting 
the probe 
towards the RV 
outflow view 
will demonstrate 







and motion and 
CFD assessment 
of MR can be 
performed at all 
levels7. The 
same segmental 










imaging plane at 
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the level of the 
MV is optimised 
to demonstrate 
the diastolic 
excursion of the 
mitral leaflet 








view of the 
leaflets. An off-
axis and more 
longitudinal 
imaging plane 
results in the LV 
appearing more 
elliptic in shape. 
The ventricular 
surface of the 
MV leaflets is 
visualised in the 
PSAX view 
with scallops 
three to one seen 
from left to 
right. The PM 
commissure is 
adjacent to 




Page 72 of 116Accepted Manuscript published as ERP-20-0034.R2. Accepted for publication: 27-May-2021
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 06/17/2021 11:28:36AM
via free access








visually. CFD is 
placed over the 
MV to assess for 













the whole valve 
anatomy and 
can help identify 
regurgitant 
orifice position 
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plane of the 
A4C view
Image 13
Image 14 - 
Visual 
assessment 
























wall.  The 
scallops usually 
imaged in the 
A4C view are: 
A3 / A2 and P1
The A2C view 




walls. In this 
view the MV 
leaflets are: P3 
adjacent to the 
inferior wall, P1 




inferior to the 
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in the image) 
with A2 seen in 
the centre of the 
valve.
The A3C view 







imaging plane is 
through the 
centre of the 
MV, 
demonstrating 
scallops A2 and 
P2
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Table 1. MV anatomy and TTE imaging view
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Table 2 - Carpentier’s classification
Type 1 – Normal leaflet motion
The predominant cause of type 1 MR is annular dilation. Although this is more 
commonly due to LV dilatation, significant LA dilatation is also increasingly 
recognised as an underlying cause (typically associated with atrial fibrillation). 
However, in rare cases, type 1 MR may be caused by a leaflet perforation secondary 
to either infective endocarditis or an iatrogenic complication of cardiac surgery.
Type 2 MR - Excessive leaflet motion
Type 2 MR occurs secondary to leaflet prolapse. Severe MR secondary to papillary 
muscle rupture may be a mechanical complication following myocardial infarction 
(MI) and is a rare cause of type 2 MR.
Type 3 - restricted leaflet motion
Type 3 MR is sub-divided into two categories: leaflet restriction during both systole 
and diastole (type 3a) and leaflet restriction during systole only (type 3b). 
Type 3a is more frequently secondary to leaflet thickening and fusion. Although 
typically rheumatic disease, post-inflammatory thickening and post-radiotherapy 
fibrosis are also recognised aetiologies. 
Type 3b occurs when the mitral leaflets are structurally normal but underlying LV 
disease results in leaflet tethering into LV and therefore leaflet restriction (typically 
seen in ischaemia of the infero-lateral wall with asymmetric systolic tethering of the 
posterior leaflet, Fig 3). It may also be seen when global LV dilation resulting in 
symmetric bileaflet tethering and reduced coaptation (Fig 3). 
Page 78 of 116Accepted Manuscript published as ERP-20-0034.R2. Accepted for publication: 27-May-2021
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 06/17/2021 11:28:36AM
via free access
Table 3 - Mechanisms and jet direction
Mechanism of central jets
- Annular dilation and reduced leaflet coaptation through LA enlargement, 
most often caused by atrial fibrillation. Usually associated with reduced 
coaptation height and leaflet flattening in systole. 
- Central jets are also seen when LV dilation leads to symmetric leaflet 
tethering and increased coaptation height.
Mechanism of posteriorly directed jets
- Anterior leaflet prolapse and or flail causes simple override of the anterior 
leaflet directing the regurgitant jet in the opposite direction.
- Ischaemic MR occurs when papillary muscle dysfunction leads to tethering of 
the posterior leaflet. This inhibits the posterior leaflet from returning to a 
normal systolic closure position and results in the anterior leaflet coapting 
with the body of the posterior leaflet, rather than the tip. This creates a 
mechanism of pseudo-prolapse that directs the jet in the direction of the 
lesion, in this case posteriorly.
- Systolic distortion of the secondary to systolic anterior motion of the AMVL
Anteriorly directed jet
- Posterior leaflet prolapse and or flail causes simple override of the anterior 
leaflet directing the regurgitant jet in the opposite direction. 
Leaflet perforation
- The direction of MR jets due to leaflet perforation depend upon the site of the 
regurgitant orifice.
- The anterior leaflet base is the most common site of iatrogenic perforation. 
Assessment post MV repair should ensure that the CFD box includes the 
whole annular ring. 
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Table 4 - Grading MR severity
Method Mild Moderate Severe
2D assessment of MV 
anatomy
Mild anatomical 







coaptation defect on 






LA size Normal (may dilate 
secondary to MS or 
moderate+ diastolic 
dysfunction)
Normal or mildly 
dilated
Always dilated
LV size Not dilated secondary 
to MR








Large central jet 
that encompasses 
>50% LA area. 
Wall adhering jet 
(Coanda effect) that 
reaches the upper 
LA or is seen to 
wrap around the 
roof of the LA
Flow convergence Not seen, brief or 
small




CW Doppler Faint/partial/parabolic Dense but 
partial/parabolic
Density similar to 
forward flow 
signal/triangular
Vena Contracta (cm) <0.3 0.31-0.79 0.7Single plane ≥
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Biplane  0.8 cm≥
Pulmonary vein flow S dominant (may be 
blunted in AF or 
diastolic dysfunction)
S dominant but may 
be blunted if 
eccentric MR (may 




Mitral forward flow A dominance (E may 
be dominant in the 
young or moderate+ 
diastolic dysfunction)
Variable E wave dominant (E 
velocity > 1.5 m/s)
EROA (cm2) <0.2 0.2 – 0.39 0.4 (may be ≥
lower in secondary 
MR or when EROA 
is elliptic)
Regurg volume (mL) <30 31-59 60 (may be lower ≥
in secondary MR or 




<30% 30 – 49% >50%
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Table 5 - Criteria for severe secondary MR
Adapted from the ASE table for grading the severity of chronic MR by echocardiography
Secondary MR can be considered severe if:
EROA 0.3 – 0.39 cm2
Regurg Vol 45 – 59 ml
RF 40 – 49%
And 3 specific criteria for severe MR
Flail leaflet
VC (single plane ≥0.7 cm, biplane ≥0.8 cm)
PISA radius ≥ 1.0 cm at Nyquist 30-
40 cm/s
Central large jet > 50% of LA area
Pulmonary vein systolic flow reversal
Enlarged LV with normal function
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Table 6 – Echocardiographic indications for MV surgery19
Left Ventricle – primary MR LV dilatation by Simpson’s biplane volume
LVESD 40 mm≥
LVEF 60%≤
Systolic Pulmonary Artery Pressure SPAP 50 mmHg>
Left Atrium Simpson’s biplane MOD 60 ml/m2 (in SR)≥
Valve anatomy Flail leaflet
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Table 7 – Unfavourable parameters for percutanous MV repair
Unfavourable parameters for MitraClip: 
primary MR
Unfavourable parameters for MitraClip: 
secondary MR
Large flail gap - separation of prolapsing 
segment from opposing leaflet >10 mm
LV end diastolic20 (LVED) dimensions 
>70mm
Flail width (size of prolapsing segment) 
>15mm
LVED volume >200ml
Small MV orifice <4cm2 LVED volume index >96ml/m2
Posterior leaflet length:
Ideally >10 mm
Can be considered >6 mm
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Report a flail 
leaflet, scallop or 
leaflet tip if part 
of the leaflet 
points towards the 
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settings (see BSE 
Minimum 
Dataset). Adjust 
the lateral CFD 
Region of Interest 
(ROI) to include 1 
cm of the LV on 
the left lateral 
border and the 
roof of the LA on 
the right lateral 
border7. The CFD 
ROI height 
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and AV CFD 
assessment should 
not be performed. 
Eccentric jet 
PISA should be 
measured in the 
view that the 
greatest radius is 
seen
Apply CFD to the 
short-axis view of 
the MV to 
identify the 
location and 




Ensure that the 
CFD box is 
optimised to 
demonstrate the 
whole MR jet but 
that temporal 
resolution is 
maintained by not 
extending the 
CFD box beyond 
what is required 
to view the 
regurgitant jet. 
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Image 10
Describe the jet 
characteristics: 
direction, width, 
how far it extends 
into the LA. 
Calculate jet area 
by tracing both 
the MR jet and 
the LA area. Jet 










for a qualitative 
assessment of MR
Place the cursor 
through the PISA 
and VC.
Enter CW mode 
and optimise, 
ensuring that the 
full MR signal is 
visualised below 
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the baseline and 
that the forward 
flow signal is 
visible above the 
baseline.
A faint CW 





as MR becomes 
more severe such 
that severe MR 
CW is of similar 
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Obtain a clear 
view of the colour 
flow through the 
mitral valve in 
PLAX, A4C or 
A2C views. 
If necessary, scan 
along the 
commissural line 
to identify the 
regurgitant orifice 
and that the PISA, 
VC and jet 
expansion are 
demonstrated. 
Zoom in on the 
colour flow 
through the mitral 
valve. Record a 
loop and scroll 
through to 
identify the image 
with maximal 
flow through the 
valve. The VC is 
the narrowest 
region of the 
regurgitant jet 
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above the valve in 








VC: This method 
is simple and 




and flow rate. 
However, low 
colour gain, poor 
acoustic 
windows, and 
inability to assess 
multiple jets can 
underestimate the 
VC. A high 
colour gain, 
irregular shape of 




Image 16 Zoom on the 
mitral valve and 
Page 91 of 116 Accepted Manuscript published as ERP-20-0034.R2. Accepted for publication: 27-May-2021








Nyquist limit to 
between 20 and 
40 cm/s (tip: a 
lower 
Nyquist limit is 
more obvious 




the remainder of 
the study at a 
lower alias 
velocity). 
Once the PISA is 
clearly seen, 
gently tilt the 
probe back and 
forth to scan 
through the PISA 
and identify the 
greatest radius. 
Freeze and scroll 
through the image 
to the point of the 
greatest radius, 
bearing in mind 
that the PISA 
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Image 18
Measure from the 
leaflet tips to the 
maximum PISA 
height (tip: 
once the height 
has been 
measured, supress 
CFD from the 
image to ensure 
that the PISAr 
measure is from 
the leaflet 
surface). 




image and place 
the cursor through 
the centre of the 
orifice (tip: place 
the cursor through 
the highest PISA 
radius and VC). 
Enter CW mode 
and optimise the 
signal according 
to the guidance 
above. 
Trace the MR 
signal. Aim to 
measure the MR 
CW signal during 
a similar R-R as 
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that of PISA 
measure.
Early or late 
systolic MR jets 
should be traced 
accordingly. 
Estimate of 
EROA alone, by 
measuring just 
MR Vmax, is not 
recommended in 
this scenario and 






Calculate the LV 
SV at the level of 
the LVOT 
according to the 
guidance above. 
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Zoom on the MV 
in the A4C view 
and apply CFD. 
Place the cursor at 
the leaflet tips and 
enter PW mode. 
Optimise 
the PW signal. 
Freeze the image 
and trace the 
Doppler signal. 
Zoom on the MV 
in the A4C view, 
ensure that the 
full annular 
diameter is 
included in the 
image. 
Freeze the image. 








calculating SV at 
both sites. 
Subtract the 
LVOT SV from 
the MV SV, the 
difference is 
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Image 24 Place sample 
volume (1–3 mm) 
at level of the MV 
leaflet tips in 
diastole.
Use of CFD can 
help to align with 
the centre of 
trans-mitral flow.
Measure at end 
expiration
Emax: peak 
velocity in early 
diastole
Amax: peak 
velocity in late 




from peak E wave 
to end of E wave 
signal27.
E wave >1.5 m/s 
is suggestive of 
severe MR in the 
absence of high-
flow states and 
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MS. An E/A ratio 












use of CFD can 
help locate the 
pulmonary veins. 
The right lower 
pulmonary vein 
(RLPV) is most 
likely adjacent to 
the atrial septum 
in the A4C view, 
with the right 
upper pulmonary 
vein likely to be 
visualised in the 
A5C view39
Place sample 
volume (1–3 mm) 
1–2 cm into the 
vein.
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PulV S: peak 
velocity in early 
systole (after 
QRS)
PulV D: Peak 
velocity in early 
diastole.
Report systolic 
flow reversal or 




that increases left 
atrial pressure can 





PV flow is 
reported. Because 
PulV S flow 












LVEF should be 
used routinely to 
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assess LV size 
and systolic 
function. 













dysfunction in the 
setting of serial 
echocardiograms 
and may help 
determine 
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volume should be 
estimated using 
2D imaging from 
the A4C and A2C 
views. As the 
long-axis 
dimensions of the 






assessment do not 
demonstrate the 
maximal LA 
volume. The A4C 
and A2C images 
acquired for LA 
measurement 
should therefore 
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However, due to 
the superior 
reproducibility 
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Table 9 - Characteristics that identify unfavourable outcome to MV repair surgery

























Zoom on the 
mitral valve in the 
parasternal long-
axis view.
Freeze the image 
and scroll through 
to mid systole.
Draw a line 
between the 
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the plane of the 
annular line
Once coaptation 
height has been 
measured, the 
area between the 
annular plane and 
the atrial surface 






Freeze the image 
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Adjust the depth 
of the image to 
focus on the LV. 
Freeze the image 





dimension at the 
longest/widest.
Divide the basal 
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Table 10 – Grading MS severity
Mild Moderate Severe
Specific finding
- Mitral Valve Area
>1.5 cm2 1.0 cm2 – 1.5 cm2 <1 cm2
Supportive finding








Adapted from the EAE/ASE table for grading the severity of MS by echocardiography
Page 105 of 116 Accepted Manuscript published as ERP-20-0034.R2. Accepted for publication: 27-May-2021
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 06/17/2021 11:28:36AM
via free access


































































most of the 
valve leaflets
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Table 12 - Guide to image acquisition in mitral stenosis














tip thickness in 
mid-diastole and 
describe the 
degree of leaflet 
restriction
Describe the 
extent of annular 
calcification and 
how far this 










Zoom on the 
MV in the A4C 
view.
Apply CFD to 
identify the 
centre of the 
MV orifice and 
direction of 
flow. 
Place the cursor 
through the 
centre of the 
orifice and 
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with the flow 
(tip: place the 
cursor through 
the highest PISA 










images can lead 
to 
overestimation 










In the PSAX 
view at the level 
of the MV, find 
the plane of the 
leaflet tips by 
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valve. Once in 
the correct 
plane, zoom on 
the valve and 
freeze. Scroll 
through the loop 
to find the point 
in diastole when 
leaflet excursion 
is at its greatest.
Trace along the 
blood-tissue 
interface of the 
leaflet tips (tip: 




onto the MV 
orifice, applying 

















can help ensure 
that orifice 
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Table 12 - Guide to image acquisition in mitral stenosis
planimetry is 
performed at the 
leaflet tips. 
Place the cursor 
at the level of 
the MV tips and 
enter orthogonal 
plane imaging to 
demonstrate the 
MV orifice, the 
MVA can then 
be traced. 
Limitation: Off 
axis imaging in 
the PLAX plane 
will lead to an 
oblique image of 
the MV and 
overestimation 






In the PSAX 
view at the level 
of the MV, 
acquire a 3D 
zoom dataset; 
this should be 
optimised to 
Page 110 of 116Accepted Manuscript published as ERP-20-0034.R2. Accepted for publication: 27-May-2021
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 06/17/2021 11:28:36AM
via free access
Table 12 - Guide to image acquisition in mitral stenosis
include the 
entire mitral 
annulus but no 








crop the dataset 
to identify three 
planes of the 
valve.
Scroll through 
the loop to find 
the point in 
diastole when 
leaflet excursion 
is at its greatest. 
Adjust the plane 
of view that is 
en-face with the 




Trace along the 
blood-tissue 
interface of the 
leaflet tips to 
measure MVA.
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Table 12 - Guide to image acquisition in mitral stenosis
A4C Image 10
P½t
Apply CFD to 
the A4C to 
identify the MV 
orifice. Place the 
cursor through 
the centre of the 
orifice (tip: 
when a 
PISA is seen 






Enter CW mode, 











signal gain and 
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Table 12 - Guide to image acquisition in mitral stenosis
deceleration 
slope from the 
peak of the 
signal to the 
baseline of 0 
cm/s. 








patient is in AF, 
measure 










LV SV is 
calculated at the 
level of the 
LVOT by 
multiplying the 
CSA by LVOT 
PW VTI (tip: 
assuming 
circular 
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Table 12 - Guide to image acquisition in mitral stenosis




of SV and 
consequently 
MVA. SV can 
also be 
estimated by 2D 
biplane and 3D 
estimates of LV 
EDV and ESV, 
similar 
limitations of 
AR and MR 
apply however) 
Apply CFD to 
the A4C to 
identify the MV 
orifice. 
Place the cursor 
through the 
centre of the 
orifice and align 
with flow (tip: 
when a PISA is 
seen within the 
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Table 12 - Guide to image acquisition in mitral stenosis
and optimise the 
signal according 
to the guidance 
above. 







Zoom on the 
MV in the A4C 
view. 
Apply CFD and 
adjust the 
baseline in the 
direction of flow 
(tip: a 
lower Nyquist 






the remainder of 
the study at a 
lower alias 
velocity). Freeze 
the image and 
scroll through to 
mid-diastole. 
Measure the 
PISAr from the 
point of the 
leaflet tips to the 
greatest radius 
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Table 12 - Guide to image acquisition in mitral stenosis
Supress CFD 
and measure the 
angle of the 
atrial surface of 










the orifice (tip: 





Enter CW mode 
and optimise the 
signal according 
to the guidance 
above. Trace the 
MV signal. 
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